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ABSTRACT 
 
Proteins in living cells can be made receptive to bioorthogonal chemistries through 
metabolic labeling with appropriately designed noncanonical amino acids 
(ncAAs). In the simplest approach to metabolic labeling, an amino acid analog 
replaces one of the natural amino acids specified by the protein’s gene (or genes) 
of interest. This approach, often termed “residue-specific incorporation,” allows 
the ncAA to be incorporated in controlled proportions into positions normally 
occupied by the natural amino acid residue. Chapter I of this thesis describes how 
this strategy has been used to track cellular protein synthesis with reactive ncAAs. 
In procedures similar to isotopic labeling, translationally active ncAAs are 
incorporated into proteins during a “pulse” in which newly synthesized proteins 
are tagged. The set of tagged proteins can be distinguished from those made 
before the pulse by bioorthogonally ligating the ncAA side chain to probes that 
permit detection, isolation, and visualization of the labeled proteins.  
Chapter II of this thesis describes how the selectivity of the method can be 
enhanced through the use of mutant aminoacyl tRNA synthetases (aaRSs) that 
permit incorporation of ncAAs not used by the endogenous biomachinery. 
Expression of a mutant synthetase in a portion of cells within a complex cellular 
mixture restricts labeling to that subset of cells. In multicellular environments, this 
approach permits the identification of the cellular origins of labeled proteins. The 
work in Chapter III illustrates how the extent of temporal and spatial resolution of 
protein labeling can be enhanced through controlled expression of mutant 
synthetases. Use of characterized promoters to direct transcription of mutant 
synthetase genes can limit labeling to relevant cells and physiological states in 
settings of increased complexity. Chapter IV presents a novel strategy with which 
ncAAs can be uniquely incorporated at the N-terminal positions of nascent 
proteins while excluded from insertion at internal positions. This approach 
permits “site-selective” tagging of cellular proteins, and its use in tagging and 
 vii 
visualization of cell-cycle dependent protein synthesis is described. 
The work described throughout this thesis was designed with the objective of 
providing powerful and versatile methods for the study of protein synthesis in 
complex multicellular systems, including live animals. Thus, Chapter V considers 
how these strategies might be used to dissect protein synthesis in living animals. 
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CHAPTER I 
Noncanonical Amino Acids in the Interrogation of 
Cellular Protein Synthesis 
 
CONSPECTUS 
Proteins in living cells can be made receptive to bioorthogonal chemistries 
through metabolic labeling with appropriately designed noncanonical amino 
acids (ncAAs). In the simplest approach to metabolic labeling, an amino acid 
analog replaces one of the natural amino acids specified by the protein's gene 
(or genes) of interest. Through manipulation of experimental conditions, the 
extent of the replacement can be adjusted. This approach, often termed 
residue-specific incorporation, allows the ncAA to be incorporated in 
controlled proportions into positions normally occupied by the natural amino 
acid residue. For a protein to be labeled in this way with an ncAA, it must 
fulfill just two requirements: (i) the corresponding natural amino acid must 
be encoded within the sequence of the protein at the genetic level, and (ii) the 
protein must be expressed while the ncAA is in the cell. Because this 
approach permits labeling of proteins throughout the cell, it has enabled us to 
develop strategies to track cellular protein synthesis by tagging proteins with 
reactive ncAAs. In procedures similar to isotopic labeling, translationally 
active ncAAs are incorporated into proteins during a "pulse" in which newly 
synthesized proteins are tagged. The set of tagged proteins can be 
distinguished from those made before the pulse by bioorthogonally ligating 
the ncAA side chain to probes that permit detection, isolation, and 
visualization of the labeled proteins. Noncanonical amino acids with side 
chains containing azide, alkyne, or alkene groups have been especially useful 
in experiments of this kind. They have been incorporated into proteins in the 
form of methionine analogs that are substrates for the natural translational 
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machinery. The selectivity of the method can be enhanced through the use of 
mutant aminoacyl tRNA synthetases (aaRSs) that permit incorporation of 
ncAAs not used by the endogenous biomachinery. Through expression of 
mutant aaRSs, proteins can be tagged with other useful ncAAs, including 
analogs that contain ketones or aryl halides. High-throughput screening 
strategies can identify aaRS variants that activate a wide range of ncAAs. 
Controlled expression of mutant synthetases has been combined with ncAA 
tagging to permit cell-selective metabolic labeling of proteins. Expression of a 
mutant synthetase in a portion of cells within a complex cellular mixture 
restricts labeling to that subset of cells. Proteins synthesized in cells not 
expressing the synthetase are neither labeled nor detected. In multicellular 
environments, this approach permits the identification of the cellular origins 
of labeled proteins. In this chapter, we summarize the tools and strategies 
that have been developed for interrogating cellular protein synthesis through 
residue-specific tagging with ncAAs. We describe the chemical and genetic 
components of ncAA-tagging strategies and discuss how these methods are 
being used in chemical biology. 
INTRODUCTION 
Shortly after the discovery of deuterium by Urey and co-workers, Rudolph 
Schoenheimer suggested that isotopically tagged cellular constituents could 
be used to trace and identify the products of metabolic reactions.(1) In 1938, 
Schoenheimer reported the first metabolic labeling of proteins with an 
isotopically tagged amino acid: in rats fed 15N-labeled tyrosine, it was found 
that a fraction of the amino acid was retained within the animal in the form of 
protein.(2) In the following decades, delineation of the mechanism of protein 
synthesis would stimulate the prospect that other non-naturally occurring 
amino acids might be incorporated into proteins. By 1956, this idea was 
validated by the demonstration that selenomethionine (Se-Met, Figure 1.1) 
could be used by bacterial cells to make proteins.(3) Today, hundreds of 
translationally active noncanonical amino acids (ncAAs) have been 
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identified, and recent progress in the incorporation of reactive ncAAs, 
combined with developments in bioorthogonal chemistry, have led to new 
ways to trace the lives of proteins.  
Proteins in living cells can be made receptive to bioorthogonal chemistries 
through metabolic labeling with appropriately designed noncanonical amino 
acids (ncAAs). In the simplest approach to metabolic labeling, an amino acid 
analog replaces one of the natural amino acids specified by the protein’s gene 
(or genes) of interest. Through manipulation of experimental conditions, the 
extent of the replacement can be adjusted. This approach, often termed 
residue-specific incorporation, allows the ncAA to be incorporated in 
controlled proportions into positions normally occupied by the natural amino 
acid residue. For a protein to be labeled in this way with an ncAA, it must 
fulfill just two requirements: (i) the corresponding natural amino acid must 
be encoded within the sequence of the protein at the genetic level, and (ii) the 
protein must be expressed while the ncAA is in the cell. 
Because this approach permits labeling of proteins throughout the cell, it has 
enabled us to develop strategies to track cellular protein synthesis by tagging 
proteins with reactive ncAAs. In procedures similar to isotopic labeling, 
translationally active ncAAs are incorporated into proteins during a “pulse” 
in which newly synthesized proteins are tagged. The set of tagged proteins 
can be distinguished from those made before the pulse by bioorthogonally 
ligating the ncAA side chain to probes that permit detection, isolation, and 
visualization of the labeled proteins. 
Noncanonical amino acids with side chains containing azide, alkyne, or 
alkene groups have been especially useful in experiments of this kind. They 
have been incorporated into proteins in the form of methionine analogs that 
are substrates for the natural translational machinery. The selectivity of the 
method can be enhanced through the use of mutant aminoacyl tRNA 
synthetases (aaRSs) that permit incorporation of ncAAs not used by the 
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endogenous biomachinery. Through expression of mutant aaRSs, proteins 
can be tagged with other useful ncAAs, including analogs that contain 
ketones or aryl halides. High-throughput screening strategies can identify 
aaRS variants that activate a wide range of ncAAs. 
Controlled expression of mutant synthetases has been combined with ncAA 
tagging to permit cell-selective metabolic labeling of proteins. Expression of a 
mutant synthetase in a portion of cells within a complex cellular mixture 
restricts labeling to that subset of cells. Proteins synthesized in cells not 
expressing the synthetase are neither labeled nor detected. In multicellular 
environments, this approach permits the identification of the cellular origins 
of labeled proteins. 
In this chapter, we summarize the tools and strategies that have been 
developed for interrogating cellular protein synthesis through residue-
specific tagging with ncAAs. We describe the chemical and genetic 
components of ncAA-tagging strategies and discuss how these methods are 
being used in chemical biology. 
INCORPORATION OF NONCANONICAL AMINO ACIDS INTO 
PROTEINS 
Codons are assigned to amino acids through selective aminoacylation of 
tRNAs followed by accurate base-pairing between charged tRNAs and 
mRNAs. Amino acids are assigned to individual tRNAs by the aminoacyl-
tRNA synthetases (aaRSs). Manipulation of the aminoacylation step to direct 
the addition of ncAAs to tRNA has facilitated the incorporation of ncAAs 
into proteins in both site-specific and residue-specific fashion. 
Site-Specific Incorporation 
Site-specific incorporation methods allow the investigator to insert a single 
ncAA at a predetermined position in a recombinant protein. In the most 
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common approach, a TAG stop codon is introduced into the gene of interest. 
Translation of the full-length protein is enabled by introduction of a 
suppressor tRNA charged with the ncAA. Introduction of the aminoacyl-
tRNA is accomplished either by injection of a chemically misacylated 
tRNA(4) or by expression of an orthogonal aaRS/tRNA pair.(5) 
In site-specific insertion, the ncAA is incorporated into a selected protein at a 
predetermined site. Since measures can be taken to ensure that incorporation 
at the selected site does not interfere with protein structure, site-specific 
approaches are ideal for introducing ncAAs into proteins with minimal 
perturbation. However, it should be noted that nontarget proteins are labeled 
by incidental “read-through” on other transcripts that include the blank 
codon. 
Site-specific incorporation of ncAAs is a powerful technology with important 
applications in protein engineering, biochemistry, and biophysics.(6) Site-
specific incorporation of reactive side chains has been used to create useful 
protein conjugates,(7) and the incorporation of biophysical probes has 
revealed atomistic details of protein structure and function in bacteria, 
yeast,(8) and mammalian cells.(9) For a comprehensive review of site-specific 
technology, see Liu and Schultz.(6) 
Residue-Specific Incorporation 
Under normal physiological conditions, the aaRSs catalyze high-fidelity 
aminoacylation of cognate tRNAs with a collective error rate of 10–4.(10) 
However, the specificity of the synthetases can be overcome by reducing the 
concentrations of their natural amino acid substrates and supplementing the 
cellular medium with substrate analogs. This approach has been used to 
achieve residue-specific incorporation of a wide variety of useful ncAAs.  
In residue-specific incorporation, a ncAA serves as a surrogate for a natural 
amino acid and is inserted into cellular proteins at multiple sites. The rate at 
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which the ncAA replaces the natural residue can be varied to suit the 
application of interest. Under certain conditions, quantitative substitution can 
be achieved; if partial replacement is preferred (e.g., for protein tagging with 
minimal perturbation of structure and function), the extent of incorporation 
can be set by controlling the concentrations of the canonical and noncanonical 
amino acids in the medium.(11) 
For a protein to be labeled in residue-specific fashion, it must fulfill just two 
requirements: (1) the corresponding natural amino must be encoded within 
the sequence of the protein at the genetic level, and (2) the protein must be 
expressed while the ncAA is in the cell. Depending on the properties of the 
ncAA, the entire proteome may be subject to tagging. Residue-specific 
methods are therefore ideally suited for interrogating cellular protein 
synthesis. 
Throughout the last decade, ncAAs with reactive side chains have been of 
particular interest to our laboratory. In combination with rapid progress in 
the development of bio-orthogonal reactions,(12) the chemistry of ncAAs is 
providing powerful new tools for tagging and modifying proteins. Although 
reactive ncAAs have many potential uses in biology and medicine, this 
chapter will focus on their application in proteomic analysis of cells, tissues, 
and organisms. 
Azides and Alkynes in Metabolic Profiling 
The discovery and development of new bioorthogonal reactions has 
transformed chemical biology. The use of functionalized analogs of 
biomolecular building blocks, or “chemical reporters”, has permitted the 
tagging and tracking of cellular components including glycans,(13) lipids,(14) 
proteins,(15) RNA,(16) and DNA.(17) Azides and alkynes have assumed 
leading roles in many chemical reporter strategies; these functional groups 
are small, stable under biologically relevant conditions, and virtually absent 
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from cells and tissues. Furthermore, many azide and alkyne analogs of 
cellular building blocks can be incorporated into target biomolecules by the 
normal biosynthetic machinery of the cell. These analogs mimic the fates of 
their natural counterparts and can be used to track cellular metabolism. For 
detection, both azides and alkynes can be revealed by Cu(I)-catalyzed azide–
alkyne cycloaddition(18, 19) (CuAAC) to appropriately functionalized probes 
(haptens, fluorescent dyes, or affinity reagents). The azide is especially 
versatile; in addition to CuAAC, azides are also susceptible to the Staudinger 
ligation(20) and to strain-promoted ligation to cyclooctynes and their 
derivatives.(21-23) 
We have developed a set of azide- and alkyne-functionalized ncAAs to tag 
proteins and track cellular protein synthesis. In 2000, we described 
incorporation of the methionine analog homopropargylglycine (Hpg) into 
proteins expressed in Escherichia coli.(24) Although kinetic assays with 
purified E. coli methionyl-tRNA synthetase (MetRS) showed Hpg to be 
activated roughly 2 orders of magnitude more slowly than methionine, 
quantitative replacement of methionine by Hpg was observed when the 
marker protein DHFR was expressed in a Met-auxotrophic host strain. 
Shortly thereafter, in collaboration with the Bertozzi laboratory, we reported 
incorporation of azidohomoalanine (Aha), a second methionine 
surrogate.(25) Like Hpg, Aha is activated more slowly than methionine, but 
can replace methionine essentially quantitatively in recombinant proteins. In 
our first report on Aha, we demonstrated that azide-labeled proteins could be 
selectively modified by the Staudinger ligation. 
PROFILING PROTEIN SYNTEHSIS 
The cellular proteome dictates cell identity, state, and function; the proteins 
expressed in the cell drive processes such as cell division and differentiation, 
and changes in protein expression allow cells and organisms to adapt to 
signals and stresses. In order to understand how cells execute these and other 
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functions, the proteins involved in each process, including those that are 
newly synthesized, modified, or degraded, must be identified. Because the 
complexity of the proteome frustrates such studies, methods that examine 
subsets of the proteome (e.g., “phosphoproteomics”,(26) 
“glycoproteomics”,(13) and “activity-based protein profiling”(27)) have 
attracted substantial attention. 
Bioorthogonal Noncanonical Amino Acid Tagging (BONCAT) 
In 2006, Dieterich et al. introduced the BONCAT (bioorthogonal 
noncanonical amino acid tagging) method, a strategy for selective enrichment 
and identification of newly synthesized cellular proteins.(15) The BONCAT 
method as originally introduced involved pulse-labeling of cells with the 
methionine surrogate Aha. Cellular proteins made during the pulse were 
labeled with Aha and therefore susceptible to selective conjugation to alkyne-
functionalized affinity probes via CuAAC (Figure 1.2). Newly synthesized, 
affinity-tagged proteins can be enriched from the preexisting, unlabeled 
protein pool by affinity chromatography and identified by mass 
spectrometry. The BONCAT approach decreases sample complexity and 
permits direct analysis of the pool of proteins synthesized in response to 
biological cues. 
As the BONCAT method was introduced, complementary techniques for 
visualization of newly synthesized proteins were also developed. One can 
visualize newly synthesized proteins in cells by appending fluorescent dyes, 
rather than affinity reagents, to metabolically labeled proteins. Cells labeled 
with Aha or Hpg can be selectively conjugated to fluorescent or fluorogenic 
dyes; imaging of intact cells reveals the spatial distribution of proteins 
synthesized during the ncAA pulse. We have demonstrated such methods in 
bacterial cells,(28) in mammalian cells,(29) and in whole organisms. Figure 
1.3 compares mammalian cells pulsed with Aha under conditions that allow 
(top) or inhibit (bottom) the synthesis of new proteins. Robust labeling of 
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new proteins is apparent in the absence of protein synthesis inhibitors, 
indicating that active protein synthesis is underway. The absence of signal in 
cells in which protein synthesis is inhibited confirms the selectivity of the 
method with respect to labeling of newly synthesized proteins. Multicolor 
tracking of two temporally distinct populations of proteins can be achieved 
by sequential tagging with Aha and Hpg,(30) and live-cell imaging of Aha-
tagged proteins has been achieved by ligation to strained-alkyne dyes.(31) 
A CHEMICAL AND GENETIC TOOLKIT FOR PROFILING PROTEIN 
SYNTHESIS 
Increasing the sensitivity and selectivity of chemical reporter strategies 
constitutes a persistent challenge. Increased reaction yields with greater 
reproducibility,(32) as well as the design and synthesis of improved probes 
for visualization and enrichment,(33) will extend the limits of what can be 
detected. In this section, we describe recent work directed toward the 
development of new chemical and genetic tools for the interrogation of 
cellular protein synthesis with reactive ncAAs. 
An Alkene Reporter of Protein Translation 
In 1998, van Hest et al. reported the incorporation of homoallylglycine (Hag), 
an alkene-functional methionine surrogate, into recombinant proteins.(34) 
Although it is charged to tRNAMet more slowly than Aha or Hpg, Hag can 
replace methionine quantitatively in proteins expressed in Met-auxotrophic 
strains of E. coli. At the time this work was reported, it was proposed that the 
Hag side chain might serve as a handle for bioorthogonal protein 
modification. Recent developments have turned this proposal into reality. In 
2009, Davis and co-workers described specific protein conjugation through 
radical addition of a glycosyl thiol to the Hag side chain.(35) Successful 
conjugation was demonstrated on a purified Hag-labeled protein, as well as 
on a virus-like scaffold displaying 180 surface Hag residues; in both cases, 
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complete modification was observed. In a 2010 report, Song et al. described 
the use of Hag to label newly synthesized proteins in mammalian cells.(36) 
Hag-labeled proteins were biotinylated or conjugated to fluorescent dyes via 
photoinduced tetrazole–alkene cycloaddition. In earlier work, the Lin group 
demonstrated the bioorthogonality of the tetrazole–alkene cycloaddition by 
modifying a protein site-specifically labeled with O-allyl-tyrosine.(37) 
Engineering the Amino Acyl-tRNA Synthetase 
The natural biosynthetic machinery of microbial and mammalian cells 
permits the incorporation of a surprising number of ncAAs into cellular 
proteins. Nevertheless, there are substantial advantages to be gained by 
engineering the aaRS to expand the set of translationally active ncAAs. 
In 2000, in vivo analysis in E. coli suggested that trans-crotylglycine (Tcg) 
could not support protein synthesis in a Met-auxotrophic strain depleted of 
methionine. However, in vitro kinetic measurements revealed that Tcg was 
activated by the E. coli MetRS.(38) Kiick and co-workers proposed that the 
low rate of activation of Tcg limited the overall rate of protein synthesis and 
that this limitation might be overcome through overexpression of the 
synthetase. In cells that expressed a plasmid-encoded wild-type MetRS (in 
addition to the genome-encoded copy), Tcg was successfully incorporated 
into protein. 
Relaxation of synthetase specificity, either by attenuation of editing activity 
or by expansion of the amino acid binding site, can also enable incorporation 
of ncAAs. In nine of the 20 aaRSs, editing activity prevents misacylation of 
tRNA with noncognate natural amino acids.(9) Mutation in the E. coli leucyl-
tRNA synthetase (LeuRS) editing domain (T252Y) attenuates the editing 
activity of the enzyme and permits incorporation of a variety of leucine 
analogs,(39) including the ketone analog oxonorvaline (Onv).(40) The A294G 
mutation in the α-subunit of the E. coli phenylalanyl-tRNA synthetase 
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(PheRS) relaxes substrate specificity by increasing the volume of the amino 
acid binding pocket.(41) Overexpression of the mutant synthetase enables 
incorporation of a variety of reactive phenylalanine analogs including p-
bromophenylalanine (p-BrF), p-iodophenylalanine (p-IF), p-
ethynylphenylalanine (p-EtF), and p-azidophenylalanine (p-AzF).(42) 
However, overexpression of this mutant did not allow incorporation of p-
acetylphenylalanine (p-AcF). Because of the versatility of the ketone function 
in chemoselective ligations, we thought it worthwhile to seek a PheRS 
mutant that would enable its use in protein labeling. In a computational 
analysis, the crystal structure of the Thermus thermophilus PheRS complexed 
with phenylalanine was used to construct a backbone-independent rotamer 
library. Calculations accurately predicted two cavity-forming mutations that 
would enable p-AcF activation.(43) A bacterial strain harboring the PheRS 
double mutant was prepared and shown to use p-AcF as a phenylalanine 
surrogate. p-AcF-labeled proteins were readily modified through hydrazide 
addition to the side-chain ketone. 
The expression of mutant synthetases with altered substrate specificities 
expands the options available for protein labeling and proteomic analysis. 
For instance, in cells expressing the A294G mutant E. coli PheRS, p-AzF and p-
EtF may be used as substitutes for or complements to Aha and Hpg in 
protein profiling. Tagging with analogs containing aryl halides, including p-
BrF and p-IF, is also possible.(42) When first reported, these amino acids were 
proposed as handles for Pd-catalyzed cross-couplings; however, early efforts 
to adapt cross-coupling procedures to proteins in aqueous solvents were 
compromised by interference from cysteine thiols, required solvent 
degassing, and generally resulted in poor yields. In a promising recent 
development, Davis’s adaptation of the Suzuki–Miyaura coupling employing 
a pyrimidine–Pd catalyst afforded specific and high-yield coupling of aryl 
bromide and aryl iodide groups on proteins.(44) Since Pd catalysts are 
poisoned by thiols, it is important that reduction and alkylation of cysteines 
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(a standard step in sample preparation for proteomic analysis by mass 
spectrometry) be performed prior to addition of the Pd catalyst. 
As described above, the toolkit for ncAA tagging has been expanded by the 
inclusion of two analogs containing ketones.(40) Chemoselective ligations to 
p-AcF or Onv residues in proteins can be achieved by treatment with 
hydrazide- or aminooxy-functionalized probes. While ketones and aldehydes 
are found on some cellular metabolites and cofactors, they are not normally 
found in proteins; complications in ligation reactions can be avoided by first 
separating protein from other cellular constituents. However, Bertozzi has 
suggested that the intracellular presence of ketone-containing metabolites 
may restrict dye-labeling and imaging applications of ketone- and aldehyde-
labeled biomolecules to the cell surface where these functions are usually 
absent.(45) 
Combinatorial Approaches to Mutant aaRS 
Efficient screening and selection methods have been developed to enable 
rapid identification of aaRS mutants of altered substrate specificity.(6, 46, 47) 
Much of our recent effort in this area has been directed toward isolation of 
MetRS mutants that activate azidonorleucine (Anl), a long-chain variant of 
Aha. Using structure-guided mutagenesis, we constructed a library of MetRS 
mutants by randomization at three positions (L13, Y260, and H301) adjacent 
to the amino acid binding site. Clones expressing functional mutants were 
selected on the basis on their ability to incorporate Anl into the outer 
membrane protein OmpC (Figure 1.4a).(48, 49) Azides displayed on the cell 
surface were detected by ligation to a biotin–cyclooctyne reagent and 
treatment with a fluorescent avidin conjugate. Bright clones were isolated by 
fluorescence-activated cell sorting (FACS). The FACS screen uses the extent 
of fluorescence labeling as a reporter for Anl incorporation and, in turn, for 
MetRS activity toward Anl; the highest levels of OmpC expression and 
fluorescence labeling are expected in cells carrying MetRS mutants most 
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active toward Anl. Through this approach, more than 40 different MetRS 
mutants were identified, each allowing incorporation of Anl into proteins 
with varying efficiency.(47, 50) A combination of mutational and X-ray 
crystal structure analyses showed that the successful mutations eliminated 
hydrophilic contacts with the Met side chain, thereby reducing competition 
with Met and polar amino acids while creating a hydrophobic pocket for Anl 
(Figure 1.4b,c).(51) The L13N/Y260L/H301L mutant (NLL-MetRS) proved to 
be especially interesting, in that its specificity constant (kcat/KM) for activation 
of Anl was found to be slightly larger than that for methionine. 
Cell-Selective Protein Labeling 
Access to the NLL-MetRS mutant allowed us to develop a method for cell-
selective proteomic analysis.(52) Cells that express the NLL-MetRS can utilize 
Anl in protein synthesis; cells that do not express the mutant synthetase are 
inert to Anl. In a cellular mixture, only proteins from mutant cells are labeled. 
Through this approach, proteins synthesized in targeted cells can be 
selectively isolated from complex mixtures for identification by mass 
spectrometry or conjugated to fluorescent dyes for in situ visualization. In a 
first demonstration of the method, we confined protein labeling with Anl to 
bacterial cells cocultured with mammalian macrophages (Figure 1.5). Careful 
analysis of bacterial proteins in such mixtures requires enrichment because of 
the disparity in the sizes and protein contents of bacterial and mammalian 
cells; bacterial proteins typically account for less than 1% of the total protein 
content in an infection mixture.(53) Anl-tagged proteins were selectively 
ligated to biotin and separated from mammalian proteins in an infection 
lysate (Figure 1.3). The Hang laboratory has used the NLL-MetRS to activate 
the alkyne analog, 2-aminooctynoic acid (Aoa), for cell-selective labeling.(54) 
The authors used Aoa to label bacterial proteins expressed in macrophage-
internalized Salmonella typhimurium. While the NLL-MetRS was isolated from 
a screen for mutants active toward Anl, the Hang experiments show that it 
also activates Aoa. NLL-MetRS mediated labeling with Aoa required removal 
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of methionine from the culture medium, whereas Anl-labeling did not. Hang 
and co-workers found lower background in reactions between azide-
functionalized probes and Aoa-tagged proteins than in parallel experiments 
with alkyne detection reagents and Anl-tagged proteins. 
Some Considerations 
It is important to keep in mind that profiling technologies are intended to aid 
and accelerate discovery. Proteins identified in profiling experiments of the 
kind discussed here may be involved in the biological process of interest but 
may be bystanders or products of secondary effects. The possibility that 
artifacts can arise in labeling experiments is well-known, and should be a 
source of caution in interpreting results. In the methods described here, 
ncAAs are incorporated into many proteins, with unknown effects on cellular 
behavior. Artifacts are likely to be minimized by short labeling times and 
modest labeling rates, and since the methods used to track labeled molecules 
are sensitive (fluorescence microscopy and mass spectrometry), labeling rates 
of a few percent are sufficient. The labeling rate is easily controlled by 
adjustment of the relative concentrations of the amino acid to be replaced and 
the ncAA reporter. 
RECENT APPLICATIONS AND FUTURE DIRECTIONS 
ncAA-tagging strategies have been employed in recent years to interrogate 
several complex cellular processes. Examples include kinetic analysis of 
protein modification and turnover rates and imaging of newly synthesized 
proteins in neurons. 
Deal and co-workers have reported an ncAA-tagging method (designated 
CATCH-IT, for covalent attachment of tags to capture histones and identify 
turnover) to examine the dynamics of genome-wide nucleosome disassembly 
and reassembly, which are important in epigenome maintenance.(55) In the 
CATCH-IT approach, newly translated histones are tagged with Aha and 
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enter the nucleus where they are incorporated into chromatin. After tagging, 
total chromatin is isolated, and tagged nucleosomes are ligated to biotin 
probes. Newly synthesized nucleosomes are isolated by binding to 
streptavidin beads, and the associated DNA is identified on microarrays to 
determine the genome positions at which old histones have exchanged with 
new. 
Zhang and colleagues have combined tandem labeling (with Aha and an 
alkyne analog of palmitic acid) and fluorescence imaging to examine S-
palmitoylation dynamics in Jurkat cells.(56) The rate of turnover of H-RasG12 
V (determined from the Aha signal intensity in a pulse–chase experiment) 
was correlated with fatty acid cycling (from the palmitate analog). The results 
were consistent with dynamic S-acylation and minimal protein turnover 
within the 5 h time interval examined. 
Local protein synthesis in neuronal dendrites is thought to contribute to 
learning and memory, and this provided the initial motivation for 
development of the BONCAT method. This process has been examined in a 
recent report by Dieterich and colleagues in which Aha and Hpg were used 
to visualize protein synthesis in dissociated rat hippocampal neurons and in 
organotypic slices.(57) Microperfusion of the ncAA permitted direct detection 
of local protein synthesis in neuronal dendrites. The diffusion dynamics of 
newly synthesized proteins were examined by conjugation of ncAA-tagged 
proteins to quantum dots. 
In recent work by Flanagan and co-workers, Aha was used to visualize local 
protein synthesis in specific subregions of the neuronal cytoplasm in 
response to external cues.(58) DCC (deleted in colorectal cancer) is a 
transmembrane receptor that regulates protein translation in axons and 
dendrites in response to the extracellular ligand netrin. Because DCC 
colocalizes with components of the translational machinery in neuronal 
dendrites and axons, it was thought that it might regulate local protein 
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synthesis in the neuron. To probe the relation between netrin binding and 
local protein synthesis, Flanagan and co-workers used Aha to tag proteins 
made in netrin-stimulated neurons. Aha-tagged proteins were found 
throughout the neuron but exhibited discrete colocalization with DCC along 
axons, within dendrites, and at the tips of filapodia. Aha tagging was used to 
measure variations in protein synthesis activity within DCC microdomains 
by quantifying fluorescence from dye-labeled neurons. Netrin-stimulated 
cells showed marked increases in protein synthesis in DCC microdomains, 
further supporting a role for netrin binding in the positive regulation of local 
translation. 
Future Directions 
While there are many promising applications of ncAAs in protein 
engineering and molecular medicine,(7, 59, 60) this Account has focused on 
the incorporation of reactive ncAAs and their use as analytical tools in 
chemical biology. We continue to develop ncAA-tagging strategies by 
creating new ncAAs, engineering new aaRS mutants, and preparing new 
probes. In collaboration with colleagues, we are pursuing studies of host–
pathogen interactions and cell signaling, as well as methods for interrogating 
protein synthesis in live animals. 
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Figure 1.1 
 
Structures of the amino acids discussed in this chapter. ncAAs shown in 
blue are substrates for the natural translational machinery, the analog shown 
in green requires overexpression of wild-type MetRS, and those shown in red 
require expression of mutant aaRSs. 
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Figure 1.2 
 
 
 
Detection and identification of newly synthesized proteins. ncAA-tagged 
proteins can be ligated to affinity probes for enrichment and identification or 
to dyes for visualization by in-gel fluorescence scanning or fluorescence 
microscopy. 
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Figure 1.3 
 
 
 
Visualization of newly synthesized proteins. Imaging of mammalian cells 
pulsed with Aha in the absence (top) or presence (bottom) of the protein 
synthesis inhibitor anisomycin. The left-most panel in each row shows the 
image formed by dye-labeling of newly synthesized proteins (green). 
Additional panels show mitochondria (red), nuclei (blue), and panel 
overlays. 
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Figure 1.4 
 
 
 
Library screen for MetRS mutants. (a) Library screen for MetRS mutants that 
allow Anl incorporation into cellular proteins. (b) X-ray crystal structure of a 
MetRS mutant (L13S/Y260L/H301L) bound to Anl (spheres).  (c) Mutations 
(spheres) that accommodate Anl (sticks and dots) within the MetRS binding 
pocket.  
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Figure 1.5 
 
 
 
Cell-selective labeling in mixtures of bacterial and mammalian cells. Cell-
selective labeling in mixtures of bacterial and mammalian cells. Macrophages 
(red) infected by E. coli cells that express GFP (top) or the NLL-MetRS 
(bottom) labeled with Anl. Proteins expressed in bacterial cells that express 
the NLL-MetRS are labeled with Anl. The control bacterial strain was bound 
and internalized by macrophages (as confirmed by detection of GFP) but 
exhibited no Anl incorporation. In neither case were macrophage proteins 
labeled. 
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CHAPTER II 
Cell-Selective Metabolic Labeling of Proteins 
ABSTRACT 
Metabolic labeling of proteins with the methionine surrogate azidonorleucine 
can be targeted exclusively to specified cells through expression of a mutant 
methionyl-tRNA synthetase (MetRS). In complex cellular mixtures, proteins 
made in cells that express the mutant synthetase can be tagged with affinity 
reagents (for detection or enrichment) or fluorescent dyes (for imaging). 
Proteins made in cells that do not express the mutant synthetase are neither 
labeled nor detected. 
INTRODUCTION 
Time-dependent changes in cellular proteomes can be monitored via a 
variety of powerful electrophoretic and spectroscopic methods. Traditionally, 
radiolabeled amino acids have been used to label proteins synthesized during 
an amino acid ‘pulse’; labeled proteins can be distinguished from preexisting 
(unlabeled) proteins through electrophoretic separation followed by 
radiographic detection.1 More recently, mass spectrometry has enabled the 
use of stable isotopes in amino acid pulse labeling.2 
In 2006, Dieterich and co-workers introduced the BONCAT (bio-orthogonal 
non-canonical amino acid tagging) strategy for selective enrichment and 
identification of newly synthesized proteins in cells.3,4 The BONCAT 
approach reduces sample complexity and permits direct analysis of the 
primary protein synthesis response to stimuli. Bio-orthogonal functional 
groups5 are introduced into proteins by pulse-labeling with reactive, non- 
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canonical amino acids. Labeled proteins are selectively modified with affinity 
tags for enrichment;6,7 removal of unlabeled proteins simplifies subsequent 
analysis and identification by mass spectrometry. 
All of these methods suffer from limitations when experiments are 
performed in systems that contain multiple cell types. Because incorporation 
of amino acids is non-specific with respect to cell identity, proteins from all 
cell types are labeled. In studies of interactions between different cell types in 
a single organism, the origin of the identified proteins can be difficult to 
ascertain because the cells share a common genome. When interactions 
between cells of different genomes are studied, detection of low abundance 
proteins can be problematic. In infection studies, for example, the protein 
content of the larger host cells can overwhelm that of the pathogen8 and limit 
detection and identification of the proteins of primary interest. In complex 
bacterial communities where hundreds of organisms can occupy a common 
biological niche,9 probing the proteome of a single species in its natural 
context is an even greater challenge. 
RESULTS AND DISCUSSION 
To address these difficulties, we describe here a versatile method for cell-
selective protein labeling in mixed cellular environments. To achieve selective 
labeling, we employ non- canonical amino acids that are excluded by the 
endogenous protein synthesis machinery (Fig. 2.1a). These amino acids face 
discrimination by the quality control mechanisms found at the level of 
aminoacyl-tRNA synthetases;10 they are not charged to tRNA and are not 
used in protein synthesis. By screening libraries of methionyl-tRNA 
synthetase (MetRS) mutants from Escherichia coli11,12 we have identified a 
mutant synthetase (NLL-MetRS) (Supplementary Fig. 2.1) that efficiently 
appends azidonorleucine (2, Fig. 2.1b) to cognate tRNA. Cells bearing the 
mutant MetRS are able to utilize 2 as a surrogate for methionine (1) in protein 
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synthesis. Wild-type cells are inert to 2; proteins made in these cells utilize 
only methionine and are not labeled (Fig. 2.1a). In co-culture, protein labeling 
is restricted to mutant cells. 
To validate this approach, we first confirmed that incorporation of 2 into 
newly synthesized proteins is dependent on expression of the mutant 
synthetase. An E. coli strain (DH10B/pJTN1) constitutively expressing a 
plasmid-borne copy of NLL-MetRS was pulse-labeled with 2 and compared 
to a control strain (DH10B/pQE-80L) that did not express the enzyme. 
Separate cultures of the two strains were grown in minimal medium 
containing the twenty canonical amino acids. When the cell density reached 
OD600 = 0.5, cells were pulse-labeled with 1 mM 2 for 10 m. Control cells 
were pulsed in the same fashion with 1, or incubated with the protein 
synthesis inhibitor chloramphenicol prior to labeling with 2. Cell lysates of 
each culture were probed for incorporation of 2 via Cu (I) catalyzed 
ligation13,14 to biotin- FLAG-alkyne (4) followed by Western blotting with 
protein detection by anti-FLAG antibody. The results of these experiments 
indicated that only proteins synthesized in cells constitutively expressing the 
NLL-MetRS (DH10B/pJTN1) were labeled with 2 and susceptible to ligation 
to 4 (Supplementary Fig. 2.2). A second control strain, in which the wild-type 
synthetase was over-expressed, was also inert to labeling (Supplementary 
Fig. 2.1). 
The behavior observed in separate cultures was maintained when cells were 
incubated in co- culture to simulate a complex, mixed cellular environment. 
Two different heterologous proteins were employed as markers for the cells 
of origin to distinguish between NLL- expressing and wild-type E. coli. An E. 
coli strain (DH10B/pJTN2) expressing the NLL- MetRS was programmed to 
express green fluorescent protein (GFP) upon induction with isopropyl β-D-
1-thiogalactopyranoside (IPTG). The control strain (DH10B/pJTN3) carried 
an IPTG-inducible gene for the marker protein DHFR. Both marker proteins 
were His- tagged to enable Ni-affinity purification and detection with Penta-
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His antibody. Individual cultures of these bacterial strains were grown to 
OD600 = 1.0 and a third culture was created by mixing cells in a volumetric 
ratio of 1:2 (DH10B/pJTN2:DH10B/pJTN3). To initiate labeling, 1 mM 2 was 
added to each of the three cultures and expression of marker proteins was 
induced with 1 mM IPTG for 3 h. Cell lysates from all three samples were 
subjected to Cu (I) catalyzed azide-alkyne ligation to 4, and marker proteins 
were isolated by Ni-affinity purification. Western analysis (Fig. 2.2a) of 
isolated proteins with Penta-His antibody revealed the expected expression 
patterns from the three cultures. In striking contrast, analysis of blots with 
streptavidin-HRP (for detection of conjugation to 4) revealed exclusive 
modification of GFP, the marker protein synthesized in cells expressing NLL-
MetRS. DHFR isolated from control cells exhibited no such modification. N-
terminal protein sequencing indicated 10-20% replacement of 1 by 2 in the 
GFP marker protein. 
To demonstrate further the utility of this approach, we used fluorescence 
microscopy to distinguish proteins made in cells expressing the NLL-MetRS 
from those made in cells that do not express the mutant synthetase. The 
control strain (DH10B/pJTN4) expressed an IPTG-inducible GFP while the 
strain (DH10B/pJTN5) constitutively expressing the NLL-MRS carried an 
IPTG-inducible DHFR. Labeling of individual and mixed cultures were 
performed as described earlier. After pulse-labeling with 2 and induction of 
protein synthesis, cells were collected by centrifugation and washed prior to 
Cu (I) catalyzed labeling of cells with dimethylaminocoumarin-alkyne (5). 
After washing with PBS to remove excess dye, cells were imaged by 
fluorescence microscopy. The results (Fig. 2.2b) were consistent with those of 
the Western analysis; the coumarin fluorescence was confined to cells that 
express NLL-MetRS. Control cells expressing GFP were inert with respect to 
labeling, as indicated by the absence of coumarin emission from these 
samples (Supplementary Fig. 2.3). 
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Cell-selective protein labeling can also be accomplished in systems containing 
mixtures of bacterial and mammalian cells. Murine alveolar macrophages 
were infected with E. coli cells that constitutively express the NLL-MetRS 
(DH10B/pJTN1) or with control bacterial cells that express a GFP marker 
protein (DH10B/pJTN4). Prior to infection, 2 mM 2 was added to the 
macrophage medium; to initiate infection, bacteria were added to the culture 
medium and co-incubated for 35 m at 37 °C. Cells were fixed, permeabilized, 
and subjected to Cu (I) catalyzed conjugation to TAMRA-alkyne (6, 
Invitrogen). Bacteria were both bound and internalized by macrophages as 
confirmed by confocal microscopy and three- dimensional analysis 
(Supplementary Movie 1 online). Macrophage-associated bacterial cells that 
express the NLL-MetRS exhibited strong fluorescence emission from 6 (Fig. 
2.3a). The control bacterial strain was bound and internalized by 
macrophages (as seen by detection of GFP, Supplementary Fig. 2.4 online) 
but exhibited no conjugation to 6 above background (Fig. 2.3a). To confirm 
protein synthesis by macrophages during the infection period, cells were 
treated with azidohomoalanine (3) in medium lacking 1 (Fig. 2.3b). Both 2 
and 3 are susceptible to ligation to alkyne-functionalized probes; however, in 
contrast to 2, 3 is activated by wild-type MetRS and does not discriminate 
between cell types4. As shown in Fig 2.3, both bacterial cells and 
macrophages were labeled with 3, whereas labeling with 2 was observed 
only in bacterial cells that express the NLL-MetRS. 
Newly synthesized bacterial proteins can be enriched from such cultures by 
affinity chromatography. Using an E. coli strain that expresses the NLL-
MetRS constitutively and GFP under induction with IPTG, we infected 
macrophages in medium containing 2 mM 2. Immediately upon infection, 
IPTG was added to initiate bacterial synthesis of GFP. After 35 m at 37 °C, the 
total cell mixture was collected by centrifugation and lysed. Proteins were 
subjected to Cu (I) catalyzed azide-alkyne ligation with alkyne-functionalized 
biotin. Biotinylated proteins were selectively enriched by collection on 
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neutravidin-agarose beads. After five washes, proteins were eluted from the 
resin with 2 mM free biotin and 2% SDS. To examine the extent of 
enrichment, the lysate, resin flow-through, washes and eluent were analyzed 
by immunoblot (Fig. 2.3c). The mammalian protein β-actin was detected with 
anti-β- actin and served as a representative macrophage protein. The bacterial 
marker GFP was detected with anti-Penta-His antibody. No actin was 
detected in the eluent, indicating at least 50-fold depletion of the mammalian 
marker. In contrast, comparison of the GFP band intensities in the eluent and 
lysate confirmed good recovery of the affinity-tagged bacterial protein. 
CONCLUSION 
The results described here illustrate the use of mutant aminoacyl-tRNA 
synthetases to enable cell-specific protein labeling with non-canonical amino 
acids. In mixed cellular systems, newly synthesized proteins in selected cells 
can be labeled with affinity reagents or fluorescent dyes for enrichment, 
identification, and visualization. This approach will enable unambiguous 
determination of the cellular origins of proteins made in complex 
multicellular systems and will provide new insight into intercellular 
communication. We are expanding the studies described here by engineering 
new amino acid/synthetase pairs and by using the azidonorleucine/NLL-
MetRS pair to examine a variety of intercellular interactions.  
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Figure 2.1 
 
 
Cell-selective labeling of proteomes with azidonorleucine. (a) Schematic 
representation of incorporation of azidonorleucine exclusively in cells 
expressing NLL-MRS. (b) Structures of amino acids and probes used in this 
study: (1) methionine, (2) azidonorleucine, (3) azidohomoalanine, (4) biotin-
FLAG-alkyne, (5) dimethylaminocoumarin-alkyne, (6) TAMRA-alkyne. 
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Figure 2.2 
 
Cell-selective protein labeling in mixed populations. (a) Western blot 
detection of marker protein expression with Penta-His antibody (left) and 
with streptavidin-HRP (right). DHFR was made in cells lacking the NLL-
MetRS (WT) and GFP in cells expressing the NLL-MetRS (NLL); both 
proteins contain multiple ATG (Met) codons (7 in DHFR and 8 in GFP). 
Azidonorleucine was added to all three cultures upon induction of protein 
synthesis. Samples from the mixed culture contain both proteins (as shown 
by Penta-His antibody detection), but only GFP is labeled with 
azidonorleucine and susceptible to labeling with 4. (b) Fluorescence images 
of cells expressing GFP but not NLL-MetRS (Wild-Type), cells expressing 
DHFR and NLL-MetRS (NLL), and a mixed culture of the two (Mixed). 
Azidonorleucine was added to all three cultures upon induction of protein 
synthesis. Cells from all three cultures were treated with 5, but only cells 
expressing the NLL-MetRS were labeled. Note that the marker proteins co-
expressed with NLL-MetRS are different in the Western blotting and 
fluorescence imaging experiments. 
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Figure 2.3 
 
Cell-selective labeling in mixtures of bacterial and mammalian cells. (a) 
Fluorescence images of mixed cultures containing bacteria attached to or 
internalized by murine alveolar macrophages. Infection was performed in 
medium containing azidonorleucine. Bacterial cells constitutively expressing 
the NLL-MetRS were labeled by TAMRA-alkyne (Constitutive NLL) while 
cells lacking the NLL-MetRS (Wild type GFP) are visible only in the GFP 
channel (Supplementary Fig. 2.4). Macrophages were labeled with 
Mitotracker Deep Red (Invitrogen) and exhibited very low TAMRA 
background emission. In all cases, conjugation of TAMRA-alkyne was 
confined to bacterial cells expressing the NLL-MetRS. (b) Fluorescence 
images of macrophage infection with wild-type bacteria performed in the 
presence of azidohomoalanine. Protein synthesis by macrophages is 
indicated by strong TAMRA-alkyne emission from both bacterial cells and 
macrophages. (c) Macrophages were infected with bacterial cells that express 
GFP under induction with IPTG and constitutively express the NLL-MetRS. 
Infection was performed in medium containing IPTG and azidonorleucine to 
facilitate bacterial synthesis and labeling of GFP. Total cell lysate from the 
infection was subjected to conjugation with alkyne-functionalized biotin; 
labeled proteins were enriched with streptavidin avidity. Bacterially 
expressed GFP and mammalian β-actin were followed by immunoblot. 
Analysis of the lysate (L), unbound flow-through (FT), washes (W1, W3, W5), 
and eluent (E) reveal a separation of bacterial and mammalian representative 
proteins. Bacterially expressed GFP was labeled with azidonorleucine and 
thus subject to conjugation to biotin and enrichment with streptavidin. 
Protein originating from macrophages, including β-actin, were not labeled 
with 2 and therefore not conjugated to alkyne-functionalized biotin. 
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Supplementary Figure 2.1 
 
Comparison of cells Anl-incorporation by cells over-expressing plasmid-
borne copies of either WT-MetRS, L13G-MetRS, or NLL-MetRS. The NLL 
mutant MetRS (NLL-MetRS) carries the mutations Leu13Asn, Tyr260Leu, 
and His301Leu and was isolated by methods described in Reference 11. 
Multiple rounds of high-throughput screening were performed in 1 mM 
azidonorleucine with increasing concentrations of methionine (from 0.01 to 
0.1 mM) for isolation of highly active clones capable of charging 
azidonorleucine in the presence of methionine. In the work described in 
Reference 11 (Link et al, 2006), screening was done in methionine-depleted 
medium. The L13G mutant identified in that work affords only low levels of 
protein labeling with azidonorleucine in media supplemented with 
methionine. Over-expression of WT MetRS is insufficient for incorporation of 
Anl as shown by the absence of signal in western blots visualized with Anti- 
FLAG-HRP. Previously-isolated MetRS mutant L13G activates Anl, but 
yields low levels of Anl incorporation in media supplemented with Met. 
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Supplementary Figure 2.2 
 
Detection of Anl-tagged proteins. Coomassie detection of proteins from cells 
pulse- labeled with azidonorleucine (left) and Western blot detection of 
proteins conjugated to biotin-FLAG-alkyne (right). Azidonorleucine labels 
newly synthesized proteins in cells expressing the NLL-MetRS. Wild-type 
cells, cells not exposed to azidonorleucine, and mutant cells exposed to the 
protein synthesis inhibitor chloramphenicol are not labeled with 
azidonorleucine; proteins from these cells do not conjugate with biotin-
FLAG-alkyne. 
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Supplementary Figure 2.3 
 
Individual panels from imaging of mixed bacterial cultures from Figure 
2.2b. Cu-catalyzed ligation to coumarin dye is restricted to cells expressing 
the NLL-MetRS. GFP-expressing wild-type cells not expressing the mutant 
enzyme do not exhibit fluorescence from the coumarin dye. 
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Supplementary Figure 2.4 
 
Infection of macrophages is performed with control bacteria expressing 
GFP, but not the NLL-MetRS (Wild-Type/GFP). The absence of emission 
from the TAMRA indicates that both macrophages and bacteria not 
expressing the NLL-MetRS are unable to utilize 2 in protein synthesis. The 
presence of Wild-Type/GFP bacteria is confirmed through detection of GFP 
fluorescence. 
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MATERIALS AND METHODS 
Reagents 
Azidonorleucine (2) and azidohomoalanine (3) were prepared as previously 
described1, both were confirmed by 1H NMR and mass spectrometry, and 
stored at 100 mM in water at 4 °C.  The triazole ligand (Tris[(1-benzyl-1H-
1,2,3-triazol-4-yl)methyl]amine) was prepared as described previously2, 
confirmed by 1H NMR and mass spectrometry, and stored at 20 mM in 
DMSO at -20 °C.  The biotin-FLAG-alkyne reagent (4) was synthesized by 
GenScript Corporation, was determined pure by mass spectrometry, and 
stored at 5 mM in water at -20 oC. The dimethylaminocoumarin-alkyne (5) 
was synthesized as previously described3, confirmed by 1H NMR and mass 
spectrometry, and stored at 40 mM in DMSO at -20 °C.  The Click-iT 
Tetramethylrhodamine (TAMRA) Protein Analysis Detection Kit dye was 
purchased from Invitrogen and the TAMRA-alkyne (6) dye was used as 
obtained.  CuBr (99.999% purity) was purchased from Sigma and suspended 
in water at 20 mM immediately before use.   
Strains and Plasmids 
pQE-80L: was used as obtained from Qiagen.   
pJTN1: The gene encoding wild-type E. coli MetRS was isolated by digestion 
of pAJL611 with NheI.  The purified fragment containing the gene cassette 
for constitutive expression of E. coli MetRS under control of its natural 
promoter was then ligated into pQE-80L.  The mutations L13N, Y360L, 
H301L were generated by three sequential site-directed mutageneses 
according to the manufacturer’s protocol from the commercially available 
QuikChange kit (Stratagene). 
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pJTN2: pJTN1 was digested with NheI and the gene cassette for constitutive 
expression of NLL-MetRS was isolated by gel purification.  This fragment 
was inserted into the NheI site of pJTN4 to generate pJTN2. 
pJTN3: Renamed from pAJL60 previously reported4.  
pJTN4: Renamed from pQE-80L/GFPrm_AM previously reported5. 
pJTN5: pJTN1 was digested with NheI and the gene cassette for constitutive 
expression of NLL-MetRS was isolated by gel purification.  This fragment 
was ligated into the NheI site of pJTN3 to generate pJTN5. 
pJTN6: pAJL61 was digested with NheI and the gene cassette for constitutive 
expression of WT-MetRS was isolated by gel purification.  This fragment was 
inserted into the NheI site of pJTN4 to generate pJTN6. 
pJTN7: pAJL61 was subjected to site-directed mutagenesis to generate the 
L13G mutation on the region that encodes the MetRS. 
Sequencing of plasmids was performed by Laragen.  All plasmids were 
transformed into the XL-1 Blue strain of E. coli (Stratagene) for cloning.  
Transformants were grown on plates containing 200 ug ml-1 ampicillin.  For 
pulse-labeling experiments, plasmids were transformed into the DH10B 
strain of E. coli (Invitrogen).  Transformants were grown on ampicillin agar 
plates or maintained in media with 200 ug ml-1 ampicillin. 
Proteomic Pulse Labeling and Protein Conjugation Reactions 
DH10B/pQE-80L and DH10B/pJTN1 were used for this experiment.  Cells 
were diluted 1:50 from an overnight culture in LB into M9 minimal medium 
and grown at 37°C with agitation at 250 rpm.  When OD600 = 0.5 was 
reached, cells were pulse-labeled by addition of 1 mM azidonorleucine to the 
medium for 10 m.  A culture of DH10B/pQE-80L in which no 
azidonorleucine was added was used a control.  As an additional control, a 
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culture of DH10B/pJTN1 was treated with 100 ug ml-1 of chloramphenicol 
for 10 m prior to addition of azidonorleucine, to inhibit protein synthesis.  
Cells were collected by centrifugation at 5,000 g at 4°C for 5 m, resuspended 
in PBS (pH 7.8) with 10% SDS, and heated at 95°C for 5 m for lysis.  PBS (pH 
7.8) was added to each sample to bring the concentration of SDS to 1%.  
Azidonorleucine-labeled proteins were then conjugated to probe by addition 
of 200 uM triazole ligand, 25 uM biotin-FLAG-alkyne, and 400 uM CuBr.  The 
reaction was allowed to proceed for 16 h at room temperature with gentle 
agitation.  Proteins were precipitated by addition of trichloroacetic acid 
(TCA) to 10%, and the resulting pellets were washed twice with cold acetone.  
Proteins were resuspended in SDS-PAGE loading buffer and separated on 
two parallel 12% Tris-Tricine gels.  One gel was stained with Coomassie-
Brilliant Blue R-250 for non-specific detection of proteins.  Proteins from the 
second gel were transferred to nitrocellulose and blocked in PBS-Tween 
containing 5% milk for Western blot analysis with anti-FLAG-HRP conjugate 
(Sigma) at a dilution of 1:20,000.  Detection was achieved by 
chemiluminesence with Super Signal West Pico Chemiluminescent Substrate 
(Pierce) and x-ray BioMax film (Kodak).  
Comparison of Anl Incorporation in Strains Over-Expressing the WT-
MetRS, L13G Met-RS, or NLL-MetRS 
DH10B/pJTN6, DH10B/pJTN7 and DH10B/pJTN2 were used for this 
experiment.  Procedures for growth and pulse labeling of cells, as well as 
conjugation chemistry, processing and Western analysis of proteins were 
performed as described above.     
Model Protein Expression, Labeling, Conjugation, and Purification 
DH10B/pJTN2 and DH10B/pJTN3 were used in this experiment.  Cells were 
diluted 1:50 from an overnight LB culture into M9 minimal medium and 
grown at 37°C with agitation at 250 rpm.  When OD600 = 1.0 was reached a 
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third culture was generated by mixing DH10B/pJTN2 and DH10B/pJTN3 in 
a 1:2 volumetric ratio.  To initiate protein labeling and synthesis, 1 mM 
azidonorleucine and 1 mM IPTG were added to the individual cultures of 
DH10B/pJTN2 and DH10B/pJTN3, as well as to the mixed culture.  After 3 
h, cells were collected by centrifugation at 5,000 g for 5 m, resuspended in 
PBS (pH 7.8) with 10% SDS, and heated at 95°C for 5 m to lyse cells.  PBS (pH 
7.8) was added to each sample to bring the concentration of SDS to 1%.  
Azidonorleucine-labeled proteins were conjugated to probe by addition of 
200 uM triazole ligand, 25 uM biotin-FLAG-alkyne, and 400 uM CuBr 
suspension in water.  The reaction was allowed to proceed for 16 h at room 
temperature with gentle agitation.  Proteins were precipitated by addition of 
TCA to 10%, and the resulting pellets were washed twice with cold acetone.  
Proteins were resuspended in Buffer B6 with 10 uM β-mercaptoethanol and 
His-tagged proteins were isolated on Ni-NTA Spin Kit columns (Qiagen) as 
directed by the manufacturer’s protocol.  Proteins were separated on 12% 
Tris-Tricine gels, transferred to nitrocellulose, blocked with PBS-Tween 
containing 5% milk, and analyzed by Western blotting with Penta-His 
Antibody (Qiagen) at a dilution of 1:10,000 and with Streptavidin-HRP 
(Pierce) at a dilution of 1:5,000.  Antibodies were detected as described above. 
Bacterial Dye Labeling and Imaging 
DH10B/pJTN4 and DH10B/pJTN5 were used in this experiment.  Cells were 
diluted 1:50 from overnight cultures in LB into M9 minimal medium and 
grown at 37°C with agitation at 250 rpm.  When OD600 of 1.0 was reached, a 
third culture was generated by mixing DH10B/pJTN5 and DH10B/pJTN4 in 
a 1:2 volumetric ratio.  Each culture was then aliquoted into a clear-bottom, 
black 96-well plate and cells were allowed to settle for 2 h at 37°C.  To initiate 
protein labeling and synthesis, 1 mM azidonorleucine and 1 mM IPTG were 
added to each well.  After 4 h, cells were collected by centrifugation at 3,000 g 
for 5 m.  Cells were washed twice and resuspended in PBS (pH 7.8).  Dye 
labeling was performed by addition of 200 uM triazole ligand, 10 uM 
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dimethylaminocoumarin-alkyne, and 400 uM CuBr suspension with rocking 
for 16 h at 4°C.  Prior to imaging, cells were washed twice with cold PBS (pH 
7.8).  Images were obtained using a Zeiss LSM510 confocal microscope 
(LSCM) with a 100x oil immersion lens.  Images represent overlays of 
detected GFP and coumarin emission as previously described.7,8 
Macrophage Infection Pulse with Azidonorleucine, Dye Labeling and 
Imaging 
The mouse alveolar macrophage cell line MH-S was obtained from ATCC 
and maintained in RPMI medium supplemented with 10% FBS, 0.05 mM β-
mercaptoethanol, and 1% penicillin/streptomycin (Sigma) under standard 
culture conditions (37°C, 5% CO2, humidified).  DH10B/pJTN1 and 
DH10B/pJTN4 were inoculated 1:40 from an overnight culture into 2XYT 
medium.  GFP synthesis was induced by the addition of 1 mM IPTG to the 
culture of DH10B/pJTN4 at an OD600 = 0.3.  Bacterial cells were allowed to 
grow for 3.5 h after initial induction, diluted into 2XYT to obtain OD600 = 1.0, 
and placed on ice.  At 20 h prior to infection, macrophages were passaged 
into wells on a LabTek II Chamber Slide System (Nalge-Nunc) at 4x105 cells 
ml-1 in 0.5 ml maintenance media and kept under standard culture 
conditions.  Medium was removed and replaced with antibiotic-free medium 
containing 100 nM Mitotracker Deep Red (Invitrogen).  Mitochondrial 
staining took place for 30 m under standard culture conditions.  Macrophages 
were rinsed twice with fresh antibiotic-free medium and chilled to 4°C for 15 
m.  Prior to infection, 2 mM of azidonorleucine was added to the cold 
macrophage cultures.  To initiate infection, E. coli cells were immediately 
added to the medium at a multiplicity of infection of 1:100.  Cells were spun 
at 4°C at 100 g for 10 m to promote attachment of bacteria to macrophages 
and synchronize infection.  To allow internalization of bacteria, cells were 
warmed to 37°C for 35 m.  Following infection, cells were washed twice with 
PBS to remove unbound bacteria and fixed with 3.7% paraformaldehyde for 
15 m at 37°C.  Fixative was removed by washing twice with PBS.  Cells were 
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permeabilized with 0.1% Triton-X100 at room temperature for 3 m and 
washed three times with PBS (pH 7.8).  The dye labeling solution was 
prepared 5 m before addition to each well and contained 200 uM ligand, 400 
uM tris(2-carboxyethyl)phosphine hydrochloride, 200 uM CuSO4, and 
TAMRA-alkyne diluted 1:750 as obtained from the manufacturer.  Dye 
solution was added to each well and labeling was performed for 16 h at room 
temperature with gentle agitation.  The following day, cells were rinsed three 
times with PBS containing 0.5 mM EDTA and 1% Tween-20.  Well dividers 
were removed and samples were covered with mounting media (composed 
of 50% glycerol and 50% PBS) and coverslips.  Samples were imaged on a 
Zeiss LSM 510 NLO three-channel confocal microscope with a 63x oil 
immersion lens.  Mitotracker, TAMRA, and GFP were excited at 633, 543, and 
488 nm, respectively.  Images of Mitotracker and TAMRA or Mitotracker and 
GFP from the middle of a confocal stack were overlaid to create the figures.  
Bacteria appearing within the Mitotracker stain are internalized while those 
appearing on the edge are attached to the outside of macrophages. 
Macrophage Infection Pulse with Azidohomoalanine, Dye Labeling and 
Imaging 
An additional control was performed for the E.coli/macrophage experiment 
to ensure that macrophages were indeed synthesizing protein and that the 
lack of macrophage fluorescence emission in the TAMRA channel was not 
due to an inability of the macrophages to synthesize protein in co-culture.  
The control experiment was performed as above except pulse labeling was 
performed with 2 mM azidohomoalanine instead of azidonorleucine.  
Azidohomoalanine can be incorporated by the endogenous protein synthesis 
machinery and can label proteins synthesized in macrophages.  The 
experiment was performed in methionine-free medium (Dulbecco’s Modified 
Eagle’s Medium supplemented with 1% Glutamax (Sigma)).  Conditions for 
infection, dye labeling, and analysis were identical to those described above. 
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Isolation of Labeled, Bacterially Expressed Proteins from Infection 
The mouse alveolar macrophage cell line MH-S and the E. coli strain 
DH10B/pJTN2 were used for this experiment.  DH10B/pJTN2 from an 
overnight culture in LB was inoculated 1:50 in fresh LB and grown for three 
hours.  Marcophages (2.12 x 108 cells) were suspended in RPMI medium 
supplemented with 10% FBS, and 1% penicillin/streptomycin in a 125 mL 
shake flask and agitated gently with rotation at 60 rpm at 37°C.  
DH10B/pJTN2 cells were then pelleted by centrifugation at 6,000 g for 1 m, 
washed once in 0.9% NaCl, and resuspended in 0.9% NaCl.  Azidonorleucine 
was added to the macrophage medium to 2 mM, DH10B/pJTN2 was then 
added to the macrophage culture (2.12 x 109 cells) and 1 mM IPTG was 
added immediately to induce bacterial expression of GFP.  After a 35 m with 
gentle agitation at 60 rpm at 37°C, all cells were collected by two sequential 
centrifugation steps at 100 g and 6000 g respectively.  Cells were combined 
and lysed in PBS pH 7.4 with 2% SDS with heating to 85°C for 5 m.  The SDS 
concentration was diluted to 0.5%, and insoluble lysate debris was removed 
by centrifugation at 15,000 g for 30 m at room temperature.  The resulting 
solution was subjected to conjugation to the commercially available biotin-
alkyne (7) (Invitrogen).  Conjugation was performed with 200 uM triazole 
ligand, 100 uM biotin-alkyne, and 400 uM CuBr.  The reaction was allowed to 
proceed over night with rotation.  The following day, excess unreacted biotin 
was removed from the mixture using PD-10 (GE) desalting columns pre-
equilibrated with PBS pH 7.4 with 0.5% SDS.  The proteins were then 
subjected to affinity purification with Neutravidin Resin (Pierce).  Prior to 
binding, 2 mL of resin was washed with PBS pH 7.4 with 0.5% SDS then 
added to the protein solution and allowed to bind at room temperature for 1 
h with rotation.  The unbound proteins were then removed and the resin was 
subjected to five 10 mL washes with PBS pH 7.4 with 0.2% SDS.  The proteins 
were then eluted in 2 mL of PBS pH 7.4 with 2% SDS and 2 mM free biotin 
with boiling for 10 m.  The unreacted sample, unbound proteins (flow 
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through), wash 1, wash 3, wash 5, and the eluent were then subjected to 
immuno-blot using the Bio-Dot Slot-Format apparatus (Bio-Rad) to 
immobilize proteins on two nitrocellulose membranes according to the 
manufacturer’s protocol.  Both blots were blocked in PBS-Tween containing 
5% milk.  One blot was probed with Anti-Penta-His Alexa 647 Conjugate 
(Qiagen) according to supplier’s protocols.  The second blot was probed first 
with Mouse Monoclonal Anti-β-Actin Antibody (Sigma) then with a 
secondary Rabbit Anti-Mouse Cy5 (Millipore) both according to suppliers’ 
recommendations.  Blots were then analyzed by fluorescence scanning using 
the Typhoon Trio (GE). Densitometric analysis was performed using the 
companion software ImageQuant (GE). 
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CHAPTER III 
Promoter-Driven Tagging: Profiling Cellular Protein 
Synthesis Under Specific Physiological States  
ABSTRACT 
Transcriptional activity from a specified promoter can provide a useful 
marker for the physiological state of a cell. Here we introduce a method for 
tagging proteins made in cells in which specified promoters are active. 
Tagged proteins can be modified with affinity reagents for enrichment or 
with fluorescent dyes for visualization. The method allows “genetic 
dissection” of the proteome, whereby proteins synthesized in pre-determined 
physiological states can be identified.   
INTRODUCTION 
Cell function and survival rely on the proper regulation of gene expression to 
ensure that proteins are synthesized in response to internal and external 
demands. Proteins that execute basic cellular functions (“housekeeping 
proteins”) are constitutively expressed, while expression of other genes may 
be restricted to specific physiological states. For instance, in bacterial 
pathogens, ribosomal proteins may be synthesized continually whereas 
expression of virulence factors may be limited to a particular stage of 
infection of a host. These differences are controlled in large part by 
transcriptional regulation and cis-regulatory elements, such as up-stream 
promoters. The level of transcription from a promoter can reflect cellular 
demand for the associated protein, and may signify a cell’s physiological 
state. For example, transcription from the soxS promoter in Escherichia coli 
drives expression of the SoxS protein, a transcription factor responsible for 
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directing expression of dozens of genes involved in protection against 
damage by free radicals1; correspondingly, activation of the soxS promoter is 
used as an indicator of cell oxidative stress.1 In other cases, transcriptional 
activity of a particular promoter may be indicative of cell physiology while 
having no direct role in the regulation of other genes. For example, 
expression of SspH1 (a secreted virulence factor) by Salmonella typhimurium is 
limited to bacteria residing within mammalian cells2; while SspH1 has no 
known role in the regulation of other Salmonella genes, its expression is 
concurrent with that of other proteins that promote intracellular survival.  
RESULTS AND DISCUSSION 
Here we describe a method for “genetic dissection” of the proteome. We 
elaborate on an existing strategy in which expression of a specific transgene 
permits incorporation of a “metabolic tag” into newly translated proteins. In 
this approach, we synchronize tagging with specific genetic activities to 
direct the tag into proteins that are expressed concomitantly with the 
activation of a particular promoter (and thus a certain physiological state of 
the host cell).  
We previously described bio-orthogonal non-canonical amino acid tagging 
(BONCAT), a strategy for selective enrichment and identification of newly 
synthesized cellular proteins.3 In procedures similar to those used in isotopic 
labeling, azide- or alkyne-containing non-canonical amino acids (ncAAs) are 
introduced to cells during a “pulse” in which actively synthesized proteins 
are tagged. Tagged proteins are distinguished from those made prior to the 
pulse through bio-orthogonal ligation of the ncAA side chain to probes that 
permit their detection, isolation,4 and visualization.5, 6 In 2009, we reported a 
genetically-targeted strategy for confining protein labeling to specified cells 
within heterogeneous mixtures,7 by using the methionine (Met, Fig. 3.1a) 
surrogate azidonorleucine (Anl, Fig. 3.1a) as the metabolic label. In this 
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approach, we relied on expression of the L13N/Y260L/H301L mutant form 
of the E. coli methionyl-tRNA synthetase (NLL-MetRS) to enable cells to use 
Anl in competition with Met during translation.8 Cells that do not express the 
mutant enzyme are inert to Anl. In cellular mixtures, only those proteins 
made in cells that express the mutant synthetase are labeled. Through this 
approach, proteins synthesized in targeted cells can be selectively isolated 
from complex mixtures for identification by mass spectrometry or conjugated 
to fluorescent dyes for in situ visualization. 
Here we describe methods for “state-selective” labeling of cellular proteins.  
We placed the gene encoding NLL-MetRS under control of two promoters of 
interest and compared the patterns of protein synthesis observed in active 
and inactive transcriptional states. We anticipated that when the promoter is 
inactive (or repressed), NLL-MetRS would not be expressed and proteins 
would not be subject to Anl-labeling (Fig. 3.1b). However, under inducing 
conditions where transcription from the promoter is active, NLL-MetRS is 
expressed and newly synthesized proteins can be tagged with Anl (Fig. 3.1c).  
To demonstrate this approach, we first used arabinose induction of the PBAD 
promoter to drive expression of the mutant synthetase. The combined 
negative and positive control of transcription from the PBAD promoter yields 
an “off/on” genetic switch that permits tightly controlled target gene 
expression in E. coli.9  We inserted a DNA sequence encoding NLL-MetRS 
into a plasmid downstream of the PBAD and ara operon regulatory elements. 
We transformed the resulting construct into E. coli cells and compared 
protein labeling under non-inducing and inducing conditions (Fig. 3.1d). 
Following a 10-minute pulse with Anl, cell lysates were subjected to Cu (I)-
catalyzed ligation10 to an alkyne probe (Alkyne-TAMRA, Fig. 3.1a) for 
selective modification of Anl-tagged proteins.  After separation of proteins by 
SDS-PAGE, in-gel fluorescence scanning revealed proteome-wide 
incorporation of Anl in arabinose-induced cells. Proteins from cells grown 
under non-inducing conditions did not exhibit significant labeling. NLL-
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MetRS expression, as determined by western blot analysis, was consistent 
with both PBAD transcriptional behavior and fluorescence detection of Anl-
tagged proteins (Fig. 3.1e).  
Next, we examined promoter-driven tagging following activation of the 
oxidative stress response in E. coli. We placed NLL-MetRS expression under 
control of SoxR, an oxidative stress sensor and transcription factor that is 
constitutively expressed in inactive form.1,11 SoxR contains two iron-sulfur 
clusters that are subject to one-electron oxidation or nitrosylation by 
superoxide and nitric oxide, respectively12. SoxR binds the promoter that 
controls expression of the soxS gene; transcription from this promoter is low 
when SoxR is in its reduced, inactive state. Upon activation of SoxR by 
superoxide or nitric oxide, strong expression of SoxS is driven from the soxS 
promoter. The SoxS protein, also a transcription factor, is responsible for 
activating the cellular response to superoxide and nitric oxide, and 
coordinates expression of more than forty genes involved in detoxification 
and oxidative-damage repair. 
To synchronize labeling with the oxidative stress response, we placed the 
NLL-MetRS gene under control of the SoxRS regulon by positioning it 
directly downstream of the soxS promoter (see Methods). The resulting 
construct was introduced to E. coli cells via a low-copy number plasmid such 
that, in addition to control of chromosomally encoded SoxS, the SoxRS 
regulon was also responsible for directing expression of NLL-MetRS (Fig. 
3.2a). As described earlier for the PBAD system, we examined promoter-
directed protein tagging under both non-inducing and inducing conditions. 
We activated the SoxRS regulon in E. coli cells grown in liquid culture by 
adding the superoxide generating agent paraquat (PQ).12 After a 15-minute 
pulse with Anl, tagged proteins were modified in lysates by strain-promoted 
conjugation to a dibenzoazacyclooctyne13 (DIBAC)-functionalized fluorescent 
dye (DIBAC-TAMRA, Fig. 3.1a) and separated by SDS-PAGE. In-gel 
fluorescence scanning yielded results analogous to those observed with the 
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PBAD system; activation of the soxS promoter with PQ (Fig. 3.2b) induced 
proteome-wide tagging of proteins synthesized by E. coli in the oxidative 
stress state. Labeling was also detected in proteins from cells treated with 
nitric oxide (Supplementary 3.1). Proteins from cells cultured under non-
inducing conditions exhibited minimal evidence of tagging. NLL-MetRS 
expression, as revealed by western blot analysis (Fig. 3.2c), was consistent 
with the behavior of the SoxRS regulon and fluorescence analysis of protein 
tagging. Together with observations from fluorescence microscopy (Fig. 
3.2d), these data demonstrate that a promoter-driven strategy can be used to 
direct protein tagging to cells in specific physiological states.  
We achieved useful levels of protein-tagging specificity in spite of low levels 
of “leaky” expression in both the PBAD and SoxRS systems. Reduction of 
background labeling required optimization of the relative amounts of Anl 
and Met in the culture medium; we screened conditions by adjusting the 
concentration of Anl until negligible tagging was observed in non-induced 
cultures. Background signal was also reduced by using glucose (for PBAD 
catabolite repression) or thiamine (an antioxidant that reduces basal levels of 
SoxR oxidation). Use of low copy-number plasmids was essential for 
minimizing background labeling; we anticipate that a single copy of the NLL-
MetRS gene by chromosomal recombination would also yield satisfactory 
results. 
We estimate that, under the conditions used in this study, the extent of 
replacement of Met by Anl is less than 10%. This estimate was made by 
comparing the intensities of TAMRA fluorescence emitted by cells labeled 
with the SoxRS system to those of cells labeled under conditions previously 
shown to yield 10% substitution (Supplementary Fig 3.2). Similar results 
were obtained for the arabinose system (data not shown). The rate of 
substitution was sensitive to the level of NLL-MetRS induction 
(Supplementary Fig. 3.3). 
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CONCLUSION 
In this work, we demonstrated that controlled expression of NLL-MetRS can 
be used to restrict protein labeling to cells that are in a particular 
physiological state. The linking of protein tagging to promoter activity 
permits “genetic dissection” of the proteome such that proteins synthesized 
in specific cell states can be tagged and identified. In multi-cellular 
organisms, this system may be useful for identifying proteins expressed by 
specific cell types or translated during specified stages of development.  
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Figure 3.1 
 
 
 
 
 
 
 
 
Promoter-directed proteomic labeling with Anl.  (a) Structures of amino 
acids and simplified representations of probes used in this study. (b) NLL-
MetRS expression is placed under control of a promoter of interest (poi). 
When transcriptional activity of the poi is “off,” the NLL-MetRS is not 
expressed and proteins are not tagged. (c) When transcription of the poi is 
“on,” the NLL-MetRS is expressed and newly synthesized proteins are 
tagged. (d) When under control of PBAD promoter and ara operon regulatory 
elements, the NLL-MetRS can be induced by arabinose. Induced (+ arabinose 
to 0.2% (w/v)) and uninduced (- arabinose) cells were pulsed with 100 µM 
Anl. Incorporation of Anl was assessed by conjugation to alkyne-TAMRA 
and subsequent detection by in-gel fluorescence scanning (left). Arrowhead 
indicates labeling of the induced NLL-MetRS. Coomassie staining was used 
to confirm even loading of protein between lanes (right). (e) Western analysis 
of NLL-MetRS expression in uninduced (-) and induced (+) cells. 
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Figure 3.2 
 
Proteomic labeling with Anl under conditions of oxidative stress.  (a) The 
NLL-MetRS is under control of the SoxRS regulon and is activated by 
superoxide or nitric oxide. (b) Anl-tagging is activated in cells treated with 
paraquat (PQ), a superoxide generating agent. Cells were treated with PQ or 
were uninduced and subsequently pulsed with 125 µM Anl. Incorporation of 
Anl was assessed by conjugation to DIBAC-TAMRA and subsequent 
detection by in-gel fluorescence scanning (left). Arrowhead indicates labeling 
of the induced NLL-MetRS. Coomassie staining was used to confirm even 
loading of protein between lanes (right). (c) Western analysis of NLL-MetRS 
expression in induced (+PQ) and uninduced (-PQ) cells. (d) Fluorescence 
visualization of tagged proteins in induced (100 µM PQ) and uninduced (No 
PQ) cells. Detection of constitutively expressed GFP confirms presence of 
cells in both induced and uninduced cultures.  
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Supplementary Figure 3.1 
 
Proteomic labeling with Anl under conditions of oxidative stress.  The 
NLL-MetRS is under control of the soxS promoter and can be activated by 
superoxide or nitric oxide. Cells in medium containing Anl were treated with 
nitric oxide (b), paraquat, a superoxide-generating agent (c), or were 
uninduced (a).  Incorporation of Anl is detected by conjugation to biotin-
PEG-alkyne and subsequent detection by western blotting with streptavidin-
HRP 
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Supplementary Figure 3.2 
 
Tagging rate in the SoxRS system is less than 10%. E. coli cells harboring the 
pJTN1 plasmid pulsed with Anl under conditions that yield a 10% 
substitution rate are compared with E. coli harboring pSOX-NLL induced 
with paraquat and pulsed with Anl. Incorporation of Anl is assessed by 
conjugation with alkyne-TAMRA and subsequent detection by fluorescence 
microscopy. SoxRS-directed labeling with Anl yields a substitution rate of 
less than 10%, as fluorescence emission from pJTN1 cells is more intense than 
that observed with SoxRS-directed labeling. Cells constitutively expressed 
GFP, which was separately detected to confirm the presence of cells. 
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Supplementary Figure 3.3 
 
Tagging rate in the SoxRS system is dependent on the degree of induction 
of NLL-MetRS expression. The NLL-MetRS is under control of the soxS 
promoter and is activated by addition of paraquat (PQ) to the culture 
medium. As the degree of transcription from the soxS promoter is dependent 
on the concentration of PQ used, so is the level of NLL-MetRS induction.  
Cells induced with PQ and pulsed with 125 µM Anl exhibit increasing levels 
of Anl incorporation as more PQ is added. Incorporation of Anl is assessed 
by conjugation to alkyne-TAMRA and subsequent detection by fluorescence 
microscopy. Cells constitutively expressed GFP, which was separately 
detected to confirm the presence of cells. 
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MATERIALS AND METHODS 
Materials 
Anl was synthesized as previously described (Link, A.J., et al, Nat. Protoc. 2, 
1879—1883) but using Nα-boc-Lysine as the starting material instead of Nα-
diaminobutyric acid. The THPTA ligand was synthesized as previously 
described9. Structures were verified by mass spectrometry and 1H-NMR 
spectroscopy. 
TAMRA-alkyne and DIBAC-TAMRA were purchased from Click Chemistry 
Tools. Anti-PentaHis monoclonal antibody AlexaFluor647-conjugate was 
purchased from Qiagen. Coomassie Colloidal Blue staining kit was 
purchased from Invitrogen. BCA Protein Assay Kit was used to measure 
protein concentrations and was from Pierce. pREP4 encoding the bacterial 
lacIq gene was obtained from Qiagen (not to be confused with the 
commercially available mammalian pREP4). Biotin-PEG-alkyne was 
purchased from Invitrogen. pACYC was obtained from New England Biolabs 
free of cost. All other reagents were purchased from Sigma and used without 
further purification. 
Cloning 
All cloned constructs were confirmed by DNA sequencing by Laragen before 
use. 
Cloning of pJTN1 was previously described.7  
To clone pBAD33-NLL-MetRS, the gene encoding an N-terminally His-
tagged NLL-MetRS was amplified by PCR from pQE80-NLL8 using the 
following primers: 5’-atatggtaccctatcatttagaggcttccacc-3’ and 5’-
atatgagctcggccacgaaggccaggagtgaaacgatgagaggatcgcatc-3’. The resulting 
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fragment was inserted between the SacI and KpnI sites of pBAD18 using 
standard cloning procedures.  
To clone pREP4-soxS-NLL, the soxS promoter and ribosomal binding site 
sequence (as encoded on the DH10B E. coli genome) was added to the 5’ end 
of the N-terminally His-tagged NLL-MetRS by PCR using primer overhangs. 
The fragment was inserted into the NheI site of pREP4.  While this construct 
exhibited leaky expression, NLL-MetRS could still be activated using 
paraquat and nitric oxide (this contrast was used in preparing Supplemental 
Figure 3.1). Because of leaky expression, this construct was not used in 
subsequent experiments.  
To clone pSOX-NLL-MetRS, the IDT_Sox_Regulon sequence (below) was 
custom synthesized by Integrated DNA Technologies and received from the 
manufacturer on pSOX_IDT. The gene encoding the NLL-MetRS was 
amplified from pQE80-NLL by PCR using primers: 5’-
atatggatccatgactcaagtcgcgaaga-3’ and 5’-ggtggaagcctctaaatgaagatct-3’. The 
resulting fragment was inserted between the BamHI and BglII sites of 
pSOX_IDT to form pSOX_IDT_NLL. The cassette encoding the NLL-MetRS 
under control of the SoxRS regulon was amplified from pSOX_IDT_NLL by 
PCR using the primers: 5’-atatgctagccccgtgtaaaacgacggccagt-3’ and 5’-
atatgctagcagtattgagcctcaggaaacagctatgac-3’. The resulting fragment was 
inserted at the NheI site of the low-copy number pACYC177 plasmid to form 
pSOX-NLL-MetRS. DH10B E. coli cells harboring the pSOX-NLL-MetRS 
plasmid were used to generate the data displayed in Figure 3.2, 
Supplemental Figure 3.2, and Supplemental Figure 3.3. A schematic of the 
construct is shown in Figure 3.2a.  
IDT_Sox_Regulon sequence: 
5’ATATgctagcCCCGTGTAAAACGACGGCCAGTTTATCTAGTCAGCTTGATTCTAG
CTGATCGTGGACCGGAAGGTGAGCCAGTGAGTTGATTGCAGTCCAGTTACGCTGGAG
TCTGAGGCTCGTCCTGAATGATATGCGACCGCCGGAGGGTTGCGTTTGAGACGGGCG
  63 
ACAGATCGACACTGCTCGATCCGCTCGCACCCAAAAAACCCCTCAAGACCCGTTTAG
AGGCCCCAAGGGGTTATGCTATCATTATCATTAGTTTTGTTCATCTTCCAGCAAGCG
TGCGCCGGTACCTTCTTCTCCTAAGCGGTCGCCCGGGTTACGCAACGGGCAATCACT
GCGCGAAAGGCAGCCACAACCAATACATCCGTCCAGTTCGTCACGCAGCGCCACTAA
GGTATGAATGCGCCGATCCAACTCTTCTCGCCATTGGGACGAAAGCTGTTTCCACTC
TTTCGCACTTAACGTATGCCCTTCGGGCAACACGCCAAACGCTTCACCAATGGTCGC
CAGCGGAATGCCAATACGCTGAGCAATTTTGATAATTGCAACATATCGCAACACATC
ACGTTTATATCGCCGCTGATTGCCGCTGTTACGGATACTGGTAATCAACCCTTTACT
TTCATAGAAATGCAGCGCCGATACCGCCACACCGCTGCGTTTCGCCACTTCGCCGGG
GGTTAGCAGCGCTTTAATGCGGGGTAATTTCTTTTCCATAAATCGCTTTACCTCAAG
TTAACTTGAGGAATTATACTCCCCAACAGATGAATTAACGAACTGAACACTGAAAAG
AGGCAGATTTCCATGGGAGGATCCAGATCTCATCACCATCACCATCACTAAGCTTAA
TTAGCTGAGCTTGGACTCCTGTTGATAGATCCAGTAATGACCTCAGAACTCCATCTG
GATTTGTTCAGAACGCTCGGTTGCCGCCGGGCGTTTTTTATTGGTGAGAATCGGATC
GACGAGAGCAGCGCGACTGGATCACTACTGGACCGCGAGCTGTGCTGCGACCCGTGA
TCTTACGGCATTATACGTATGATCGGTCCACGATCAGCTAGATTATCTAGTCAGCTT
GATGTCATAGCTGTTTCCTGAGGCTCAATACgctagcATAT-3’ 
5’-Blue: transcriptional termination sequence (reverse) 
Green: SoxR transcription factor gene from (reverse) 
Yellow: Bi-directional regulatory sequence containing the soxR and soxS 
promoters  
3’-Blue: transcriptional termination sequence (forward) 
 
Protein Tagging with Anl 
PBAD system: 
DH10B E. coli cells transformed with pBAD33-NLL-MetRS were grown in LB 
medium supplemented with 0.2% glucose and 100 mg L-1 of ampicillin 
overnight at 37 °C with orbital shaking at 250 rpm. The following day, the 
culture was diluted 1:50 into M9 minimal medium supplemented with 40 
mg L-1 of each of the twenty canonical amino acids, 1 mM MgSO4, 0.1 mM 
CaCl2, 30 mg L-1 thiamine hydrochloride, and 0.4% (v/v) glycerol. This 
culture was grown at 37°C with orbital shaking at 250 rpm until OD600 was ~ 
0.5, at which point the culture was divided into two.  To one culture, 
arabinose was added to a final concentration of 0.2% for induction of the 
NLL-MetRS.  Ten minutes later, both cultures were pulsed by addition of Anl 
to a final concentration of 100 mM. After a 10 m pulse, cells were pelleted by 
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centrifugation at 4 °C, rinsed once with cold PBS, and pelleted again. Cell 
pellets were frozen at - 20 °C until further processing. 
SoxRS system: 
DH10B E. coli cells transformed with pSOX-NLL were grown overnight in 
SOB medium supplemented with 30 mg L-1 thiamine hydrochloride and 100 
mg L-1 ampicillin at 37 °C with orbital shaking at 250 rpm. The following day, 
the culture was diluted 1:50 into fresh SOB medium supplemented with 10 
mg L-1 thiamine hydrochloride and 100 mg L-1 ampicillin and grown at 37°C 
with orbital shaking at 250 rpm. When the culture reached an OD600 of ~ 1.0, 
the culture was diluted 1:10 into RPMI medium supplemented with 10% 
(v/v) fetal bovine serum and 10 mg L-1 thiamine hydrochloride. This culture 
was allowed to grow for 1 h. The culture was divided into two and paraquat 
was added to one culture at a final concentration of 100 mM (from a freshly 
prepared 10 mM stock in water). Ten minutes later, both cultures were 
pulsed by addition of Anl to a final concentration of 125 µM. After a 15 m 
pulse, cells were pelleted by centrifugation at 4 °C, rinsed once with ice cold 
PBS and pelleted again. Cell pellets were frozen at - 20 °C until further 
processing. 
For Supplementary Figure 3.1, DH10B cells were transformed with pREP4-
soxS-NLL and maintained in 35 mg L-1 kanamycin.  Paraquat treatment was 
done as described for pSOX-NLL, and exposure of cells to nitric oxide was 
done as described by Ding et al (ref. 11).  
Protein Conjugation and Detection 
For protein conjugation to alkyne-TAMRA, cells were lysed by suspension in 
PBS containing 1% (w/v) SDS and heated to 75 °C.  Lysates were briefly 
sonicated to shear DNA and reduce the viscosity of the solution. Protein 
concentrations were normalized by BCA assay. The conjugation reaction was 
performed according to the protocol suggested by Vu et al (ref. 9) using 10 
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µM alkyne-TAMRA and a 20 m reaction time. Reactions were stopped by 
addition of Anl to a concentration of 100 µM followed by brief vortexing. 
For protein conjugation to DIBAC-TAMRA, cells were lysed by suspension in 
100 mM Tris buffer (pH 8.0) containing 1% (w/v) SDS, and heated to 75 °C. 
Lysates were briefly sonicated to shear DNA and reduce the viscosity of the 
solution. Prior to addition of DIBAC-TAMRA, cysteine thiols were blocked 
by addition of iodoacetamide to a final concentration of 25 mM.  The blocking 
reaction was allowed to proceed for 1 h in the dark with mild agitation. 
Protein conjugation reactions were initiated by addition of DIBAC-TAMRA 
to a final concentration of 20 µM (from a 5 mM stock in DMSO). Reactions 
were allowed to proceed for 20 m with mild agitation at room temperature, 
protected from light. Reactions were stopped by addition of Anl to 100 µM 
followed by brief vortexing. 
For detection, ~ 10 µg of protein was separated on 12% Tris-Tricine SDS-
PAGE gels. Following electrophoresis, gels were imaged by fluorescence 
scanning on a GE Typhoon Trio+ fluorescence scanner with detection for 
TAMRA.  Subsequently, proteins were stained using the Coomassie Colloidal 
Blue staining kit according to the manufacturer’s protocol. Images of 
Coomassie-stained gels were also obtained on the GE Typhoon Trio+ using 
red-laser excitation of the gel and omitting the emission filter. 
Imaging 
Cultures prepared as described earlier were pulse labeled with 100 µM Anl 
for 20 m. To halt protein synthesis, cell pellets were washed with cold PBS 
containing 30 µg mL-1 chloramphenicol. Cells were fixed in 3.7% (w/v) 
formaldehyde at room temperature for 30 m, permeabilized in 0.1% (v/v) 
Triton-X 100 in PBS at room temperature for 5 m, sedimented by 
centrifugation, and resuspended in PBS. Reagents were added to the cell 
suspension to the following concentrations: 100 µM CuSO4, 500 µM THPTA 
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ligand, and 40 µM alkyne-TAMRA. The reaction was initiated by addition of 
aminoguanidine and sodium ascorbate (from 20X stocks in water) to final 
concentrations of 5 mM each. The reaction was allowed to proceed for 30 m 
at room temperature, protected from light. Cells were washed twice with PBS 
to remove excess dye and resuspended in PBS. Each cell suspension was 
applied to a 5% agarose slab and covered with a coverslip. Images were 
obtained with a Zeiss LSM510 confocal microscope using a 63X oil immersion 
lens. 
Western Blot Analysis 
Protein contents in cell lysates were normalized by BCA assay and 5 µg of 
protein from each lysate was separated on 12% Tris-Tricine SDS-PAGE gels. 
Following electrophoresis, proteins were transferred to nitrocellulose 
membranes and subsequently blocked with 5% milk in PBST. Membranes 
were probed for NLL-MetRS by addition of Anti-PentaHis AlexaFluor647-
conjugate to the blocking buffer at a dilution of 1:5,000. After 1 h incubation 
with rocking at room temperature, membranes were washed for 5 m with 
PBST. The wash was repeated three times.  Washed membranes were 
scanned on a GE Typhoon Trio+ fluorescence scanner with detection for 
AlexaFluor647. 
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CHAPTER IV 
An Alternative Interpretation of the Start Codon 
Permits N-terminal Tagging of Proteins in Mammalian 
Cells 
ABSTRACT 
The AUG codon serves two functions: it encodes methionine (Met), and 
signals the start of protein synthesis. Correspondingly, AUG is decoded by 
two forms of methionyl-tRNA: the initiator and the elongator. Selective 
intracellular charging of the initiator tRNA with the non-canonical amino 
acid azidonorleucine (Anl) permits incorporation of Anl at the N-terminal 
position of proteins. Because Anl is not charged to the elongator tRNA, it is 
not introduced at internal positions.  Here we show that Anl can be globally 
introduced at the N-termini of nascent proteins and used as a metabolic “tag” 
to track the up- and down-regulation of protein translation in mammalian 
cells. 
INTRODUCTION 
While codons are degenerate, they are rarely ambiguous. With few 
exceptions, each codon designates a signle amino acid and is decoded as such 
with high fidelity. However, one codon serves two functions: AUG encodes 
methionine (Met) and also signals the start of translation of the RNA 
message. Correspondingly, two forms of tRNAMet are used to decode AUG 
codons: initiator tRNA and elongator tRNAMet. The initiator decodes the start 
codon and incorporates Met at the N-terminal positions of proteins.1,2,3 The 
elongator form is used in decoding internal AUG codons and delivers Met to 
internal positions within polypeptide chains. As start codons and internal 
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AUG codons are interpreted through distinct mechanisms, it is possible that 
they could encode separate amino acids. For instance, if initiator tRNA were 
aminoacylated with a non-canonical amino acid and elongator tRNAMet with 
Met, then start codons and internal AUG codons would be interpreted 
accordingly. This kind of differential decoding can be achieved in cell-free 
translation systems by adding chemically misacylated initiator tRNA to 
direct N-terminal incorporation of a non-canonical amino acid.4,5 
Unfortunately, cell-free systems produce limited amounts of protein and do 
not allow direct interrogation of cellular processes. Extension of the N-
terminal incorporation strategy to cellular systems would be an important 
advance. Here we demonstrate that heterologous expression of a mutant 
methionyl-tRNA synthetase (MetRS) from Escherichia coli in the mammalian 
cytoplasm facilitates selective intracellular aminoacylation of initiator tRNA 
with the non-cannonical amino acid azidonorleucine (Anl, Supplementary 
Fig. 4.1). This strategy permits site-selective incorporation of Anl at the N-
terminal position of nascent cellular proteins.  
In early studies of tRNA recognition, researchers performed inter-species 
aminoacylations to uncover the molecular determinants governing tRNA 
specificity.6 In the methionine system, studies showed that the E. coli MetRS 
efficiently aminoacylates initiator tRNAs from different organisms (bacteria, 
yeast, plants, and animals) and various eukaryotic organelles (mitochondria 
and chloroplasts).7,8,9,10 In contrast, eukaryotic cytoplasmic elongator tRNAMet 
from yeasts, plants, and mammals were poor substrates for the E. coli 
MetRS.7,8,10,11 A particularly poor substrate was the mammalian cytoplasmic 
elongator tRNAMet, which has been reported not to bind E. coli MetRS.9 A 
mutational analysis of tRNAMet identified the enlarged anticodon loop of the 
mammalian cytoplasmic elongator as the structural element prohibiting 
recognition by the E. coli MetRS.12 Given the selectivity of the E. coli MetRS for 
the mammalian initiator, we imagined that it might enable selective 
aminoacylation of initiator-tRNA in the mammalian cytoplasm.  To explore 
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this idea, we used the L13N/Y260L/H301L triple mutant of the E. coli MetRS 
(NLL-MetRS) to activate Anl in human embryonic kidney (HEK 293) cells. 
We found Anl to be incorporated at the N-terminal positions of proteins and 
not be excluded from internal Met positions (Fig. 4.1A). 
RESULTS AND DISCUSSION 
Function of NLL-MetRS in mammalian cells 
We had previously identified the NLL-MetRS through structure-guided 
mutagenesis of the E. coli MetRS amino acid binding pocket.13,14,15 When 
expressed in bacterial cells, the mutant synthetase permits incorporation of 
Anl into protein at both N-terminal and internal positions encoding Met.13,16,17 
To confirm that the mutant bacterial synthetase was also selective for 
mammalian initiator tRNA (like the wild-type enzyme), we aminoacylated 
synthetically prepared tRNAMet following previously described procedures.18 
Our analysis revealed that, despite mutation, the NLL-MetRS exhibited tRNA 
selectivity similar to that of the wild-type enzyme (Supplementary Fig. 4.2).  
Next, we asked whether or not the NLL-MetRS was functional when 
expressed in the cytoplasm of mammalian cells. RajBhandary and coworkers 
observed that wild-type E. coli MetRS was active when expressed in monkey 
cells and that its expression increased translational initiation of a reporter 
protein.19 In order to test intracellular aminoacylation with Anl, we generated 
by transfection a human embryonic kidney (HEK 293)-derived cell line that 
constitutively expressed NLL-MetRS as a fusion with mCherry 
(Supplementary Fig. 4.3A-B). Following selection for stably transfected cells, 
we isolated a single clone to generate the HEK293-8D3 cell line 
(Supplementary Fig. 4.3C-D). Expression of the NLL-MetRS-mCherry fusion 
was confirmed by fluorescence microscopy, western analysis, and affinity 
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purification of the protein from HEK293-8D3 cells. The enzyme was soluble, 
fully intact, and broadly distributed within the HEK293-8D3 cytoplasm. 
We assessed the activity of the NLL-MetRS in HEK293-8D3 by seeking 
evidence of Anl incorporation into cellular proteins. Although previous 
studies have shown that misacylated initiator tRNAs misacylated can be 
inactive in initiation because of poor binding to eIF2,20 we were optimistic 
regarding Anl because efficient initiation with Anl has been observed in 
bacterial cells.16,17 In a preliminary analysis, we incubated HEK293-8D3 and 
control cell cultures with Anl in a 4 h “pulse.” Subsequently, cells were 
washed, fixed, permeabilized, and examined for Anl incorporation by Cu (I)-
catalyzed azide-alkyne ligation21 of AlexaFluor488-alkyne (Supplementary 
Fig. 4.1). Imaging of cells by fluorescence microscopy revealed that 
AlexaFluor488-alkyne was attached throughout HEK293-8D3 cells and 
absent from non-transfected cells (Fig. 4.1B). To confirm that Anl was 
retained within cells in the form of protein, HEK293-8D3 cells were co-
incubated with Anl and the protein synthesis inhibitor anisomycin 
(Supplementary Fig. 4.4). Following conjugation of AlexaFluor488-alkyne, 
we observed markedly decreased fluorescence emission from anisomycin-
treated cells, indicating that active protein synthesis is required for cellular 
retention of Anl. 
To verify protein labeling more directly, Anl-tagged proteins in cell lysates 
were modified via strain-promoted cycloaddition22 with a dibenzo-aza-
cyclooctyne-functionalized23 fluorescent dye (DIBAC-TAMRA, 
Supplementary Fig. 4.1). Prior alkylation of protein thiols with 
iodoacetamide eliminated the background reaction of the DIBAC-group with 
cysteine residues (Supplementary Fig. 4.5). Modified proteins were 
separated by electrophoresis and examined by in-gel fluorescence scanning. 
Proteins derived from HEK293-8D3 cells showed strong fluorescence 
emission (Fig. 4.1C), indicating incorporation of Anl throughout the 
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proteome. In contrast, proteins from non-transfected cells showed little 
evidence of labeling.  
N-terminal Tagging 
In 2006, we described bio-orthogonal non-canonical amino acid tagging 
(BONCAT), a strategy for enrichment and identification of newly synthesized 
proteins.24 In the BONCAT method, cells are pulsed-labeled with a non-
canonical amino acid tag, and tagged proteins are separted from those made 
prior to the pulse by selective modification of the non-canonical side 
chain.24,25,26,27 Use of Anl/NLL-MetRS system to achieve BONCAT labeling in 
mammalian cells appeared particularly attractive as we anticipated that 
labeling would be restructured to N-terminal positions.  Since the N-termini 
of proteins tend to be solvent exposed and flexible,28 introduction of Anl at 
these positions would be expected to cause minimal perturbation of protein 
function. 
Pulse labeling of cells with Anl is achieved by simple addition of the amino 
acid to the growth medium (fresh medium contains at least 115 µM Met). We 
tested Anl concentrations over a 128-fold range and observed incorporation 
at concentrations as low as 20 µM (Supplementary Fig. 4.6A). The extent of 
labeling could be easily adjusted by varying the amount of Anl used in the 
pulse. The band profiles of tagged proteins were independent of Anl, 
suggesting that Anl does not cause marked changes in protein expression.  
Anl was rapidly taken up by cells and incorporated into proteins; 
Anl=tagging was detected following a 15 m pulse (Supplementary Fig. 4.6B). 
Since we observed increasing accumulation of tagged proteins with 
increasing pulse length, we inferred that Anl-tagging did no cause rapid 
protein degradation. 
Enrichment of Tagged Proteins 
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We used a DIBAC-functionalized biotin reagent (DIBAC-biotin, 
Supplementary Fig. 4.1) to modify and enrich tagged proteins from the 
lysates of Anl-treated HEK293-8D3 cells. To assess the selectivity of the 
enrichment procedure, a “mock enrichment” of proteins from unlabeled cells 
was processed in parallel. Each step of the enrichment process was followed 
by coomassie staining of protein gels and streptavidin detection of 
biotinylated proteins (Fig. 4.2A-B). We did not detect coomassie-stained 
proteins in the elution of the mock-enrichment (Fig. 4.2A, lane “E”), 
suggesting that proteins enriched from HEK293-8D3 cells (Fig. 4.2B, lane “E”) 
contained very few (if any) tagged proteins. In order to confirm that the 
enriched fraction did indeed contain proteins synthesized during the pulse, 
we employed specific immunodetection of two constitutively expressed 
“housekeeping” proteins, GAPDH and β-actin. While GAPDH and β-actin 
were absent from the elution of the mock enrichment, both were present in 
the enriched fraction of HEK293-8D3 proteins (Supplementary Fig. 4.7). We 
estimated the extent of enrichment by adding purified (singly-tagged) GFP to 
untagged lysate. Following enrichment, the amount of untagged protein in 
the elution was diluted at least 120-fold and enriched GFP was concentrated 
by a more than 3-fold (Supplementary Fig. 4.8). 
Analysis of Tagged Proteins by Mass Spectrometry 
In order to confirm that Anl was introduced at the initiator position, we 
pursued direct evidence of its incorporation at protein N-termini. SDS-PAGE 
gels containing enriched proteins were divided into individual gel slices and 
treated with protease. Digested peptides were extracted before analysis by 
tandem mass spectrometry (LC-MS/MS). The resulting fragmentation data 
were used to perform a peptide-identification search in which the masses 
corresponding to DIBAC-biotin modified and unmodified Anl were included 
as acceptable substitutions for Met (Supplementary Fig. 4.9). Although we 
did not expect to find proteins containing unmodified Anl residues (as only 
streptavidin-enriched proteins were digested), it was included in the search 
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nonetheless. Also, since many proteins are subject to enzymatic Nα-
acetylation,29 the Nα-acetyl derivative of each modification was also included 
in the search (Supplementary Fig. 4.9). In an initial analysis, we identified 
more than 3,000 unique peptides of which only one exhibited evidence of 
Anl-incorporation. The N-terminal tryptic fragment of the polypyrimidine 
tract binding protein (PTBP) was detected containing Nα-acetylated Anl 
modified with DIBAC-biotin (Fig. 4.2C, Table 4.1). Western analysis 
confirmed that PTBP was indeed present in the enriched fraction (Fig. 4.2D), 
and we inferred that detection of this fragment was favorable in part because 
of PTBP’s high relative abundance in the analyzed gel slice (Fig. 4.2D, and 
red box in Fig 4.2B). We were confident in the authenticity of the observed 
spectrum (Fig. 4.2D) for the following reasons: 1) the mass of parent ion 
matched exactly with the expected mass of the substituted peptide, 2) the 
substitution was directly detected following fragmentation and appeared as 
both b- and y-ions (Fig. 4.2D, ions b1 and y13), and 3) the ion of highest 
intensity (y9) indicated peptide fragmentation N-terminal to proline, a 
cleavage that occurs with high propensity when preceded by valine.30 In total, 
we detected 15 unique PTBP peptides amounting to 43% sequence coverage 
of intact PTBP (Supplementary Fig. 4.10). Given the nature of selective N-
terminal incorporation, expected that internal PTBP peptides would not 
contain substitutions. Thus, we were pleased to find that of the 14 peptides 
corresponding to internal PTBP fragments, none displayed evidence of Anl-
incorporation (four contained one or more Met residues). 
Detection of additional modifications 
In an attempt to encourage detection of modified peptides, we enriched 
proteins using a cleavable probe in which a disulfide is positioned between 
the DIBAC group and the biotin handle (DIBAC-S-S-biotin, Supplemental 
Fig. 4.1). Following enrichment, reduction of the disulfide bond releases a 
substantial portion of the probe from proteins and the resulting structure is 
considerably smaller than that obtained with the original probe (232 amu 
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less). We performed a similar analysis as described in the preceding section 
using DIBAC-S-S-biotin instead of DIBAC-biotin. A database search for 
modifications corresponding to reduced and alkylated DIBAC-S-S-biotin 
(Supplemental Fig. 4.9) identified six additional peptides exhibiting evidence 
of Anl incorporation (Supplemental Fig. 4.11A-G, Table 4.1). Each peptide 
was the N-terminal tryptic fragment of a protein, and equivalent peptides 
containing N-terminal Met were not detected. For each protein, we identified 
9 or more unique internal peptides, with sequence coverage ranging between 
30-67%. While N-terminal peptides containing Anl were detected, no N-
terminal peptides containing Met were observed. 
Tagging of Histones 
In our early imaging experiments, we noticed that a fraction of cells exhibited 
increased fluorescence localized in the center of the cell. In dye-labeled 
HEK293-8D3 cells, these intensities co-localized with fluorescence emission 
from Hoechst 33342-stained nuclei (Fig. 4.3A), suggesting that certain nuclei 
contained higher amounts of tagged protein. Analysis of subcellular fractions 
revealed a set of highly fluorescent bands within the 10-25 kDa mass range in 
the fraction containing nuclear proteins (Supplementary Fig. 4.12). We 
verified that these proteins were histones by acid-extraction of histones from 
nuclei and DIBAC-TAMRA labeling of the isolated proteins (Fig. 4.3B). 
TAMRA fluorescence was detected in bands corresponding to the core-
histone proteins, as well as the linker histone (data not shown). Since histone 
synthesis is tightly synchronized with DNA synthesis, histones are translated 
only by cells in S phase of the cell cycle.31,32 Correspondingly, we observed 
that only a fraction of cells within imaged populations exhibited increased 
nuclear fluorescence. Also, our findings demonstrate that Anl-tagged 
histones are properly transported into the nucleus following synthesis 
(histone mRNAs are translated in the cytoplasm).  
  76 
 Since excess amounts of histones can lead to genomic instability, histone 
synthesis must be tightly controlled to match the amount required for 
chromatin assembly. Through transcriptional, post-transcriptional, and 
translational mechanisms, histone is synchronized with DNA replication. To 
further explore histone tagging, we treated cells with the DNA synthesis 
inhibitor hydroxyurea (HU). Since histone translation is tightly coupled to 
DNA synthesis, HU is also an inhibitor of histone translation. We pulse 
labeled cells with Anl in the presence and absence of HU and analyzed 
proteins by in-gel fluorescence. A side-by-side comparison of the band 
intensities showed a significant decrease in fluorescence at bands 
corresponding to histones, indicating that histone synthesis was decreased by 
HU treatment (Fig. 4.4A-B). 
Upon initial inspection of protein gels, HU appeared to selectively down-
regulate histone translation while having little or no effect on the synthesis of 
other proteins (Fig. 4.4A-B). However, after close inspection of gels, 
additional variation in band intensity between lanes could be identified. In 
order to accentuate differences within individual mass ranges, we separated 
proteins using gradient and non-gradient gels of various acrylamide 
concentrations. Using a 15% polyacrylamide gel, we detected an 
unambiguous difference at ~50 kDa (Fig. 4.4C). Because the band was absent 
from the lane containing proteins from untreated cells, and present in the 
lane containing proteins from HU-treated cells, we wondered whether it 
represented stabilized p53 tumor suppressor. The p53 tumor suppressor is a 
transcription factor that is continually synthesized in cells and is targeted for 
rapid degradation in its non-phosphorylated state.33 Under conditions of 
genotoxic stress (such as during HU treatment), p53 is stabilized by 
phosphorylation, permitting cellular accumulation of the protein.33 Detection 
of p53 expression by western blotting confirmed its stabilization in HU-
treated cells (Fig. 4C). Additional band differences between lanes were made 
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apparent after tagged proteins were enriched from cell lysates and detected 
by streptavidin (Supplementary Fig. 4.13).  
Lastly, we pulsed HEK293-8D3 in the presence or absence of HU and imaged 
the cellular distribution of Anl-tagged protein by fluorescence microscopy 
(Fig. 4.4D). In a population of HEK293-8D3 cells not treated with HU, we 
observed cells exhibiting increased nuclear fluorescence that is associated 
with histone synthesis. However, increased nuclear fluorescence was not 
seen when cells were treated with HU. Instead, fluorescence was broadly 
distributed throughout the cell with nuclear boundaries indiscernible. 
Individual punctate intensities were visible in HU-treated cells, as well as 
untreated cells that were not in S-phase (Fig. 4.4D). These intensities may 
represent localized synthesis of proteins at the rough endoplasmic reticulum, 
or membrane-bound N-terminal signal sequences of proteins that have 
entered the secretory pathway.  
Post-translational Removal of N-terminal Anl 
While all proteins are initiated with Met, N-terminal Met is post-
transnationally removed from many proteins by methionyl-aminopeptidase 
(MetAP). Recognition by MetAP is largely dependent on the identity of the 
second amino acid in the polypeptide chain; proteins containing glycine, 
alanine, or serine at the second position are most efficiently processed.34 In 
cases where the N-terminal Met of a substrate protein is replaced by a 
structurally analogous non-canonical amino acid, processing can still occur 
(albeit at lower rates).35,36 In an enzymatic assay using recombinant human 
MetAP-2 (the cytoplasmic form), we measured excision activity toward N-
terminal Anl using a model substrate. While Anl was removed by MetAP, 
processing was notably less efficient than it was for Met (Supplemental Fig. 
4.14). Of the proteins for which we had direct evidence of Anl incorporation 
(by mass spectrometry, or by confirming the identity of a TAMRA-labeled 
protein band), many were known substrates of MetAP (Supplementary 
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Table 4.2).37 It is likely that N-terminal Anl is also removed intracellularly, 
although not entirely. An illustrative example of Anl retention can been seen 
in Supplemental Figure 4.7 with the enrichment of GAPDH and β-actin. 
Despite experiencing complete removal of their N-terminal Met residues 
under natural conditions, N-terminal Anl is retained on GAPDH and β-actin 
at some fraction. Additionally, the high abundance of PTBP in enriched 
fractions (red box in Fig. 4.2B, lane “E” in Fig. 4.2C) may be in part because 
PTBP is not a MetAP substrate (and thus completely retains Anl). 
Furthermore, we found that use MetAP inhibitors could reduce the level of 
intracellular N-terminal excision of Anl (data not shown). 
CONCLUSIONS 
We have demonstrated that intracellular aminoacylation of mammalian 
cytoplasmic initiator tRNA by the E. coli NLL-MetRS can direct site-selective 
incorporation of Anl at the N-terminal positions of nascent proteins. 
Discrimination against elongator-tRNAMet by the bacterial enzyme prohibits 
incorporation of Anl at internal sites encoded by AUG, and only Met is 
inserted at these positions. Proteins synthesized by the cell can be tagged in a 
“pulse” and subsequently revealed through bio-orthogonal ligations to the 
Anl side chain. Conjugation of affinity reagents to tagged proteins permits 
their selective enrichment, and tagged protein present at less than 0.1% of 
total protein can be can be isolated from cell lysates. Enrichment of tagged 
proteins is advantageous for two primary reasons: 1) its permits direct 
analysis of proteins synthesized in response to internal and external stimuli, 
and 2) it decreases sample complexity and facilitates identification of proteins 
by mass spectrometry. Alternatively, conjugation of tagged proteins to 
detection reagents permits examination of translational profiles on SDS-
PAGE gels. Differences in protein synthesis between conditions can be 
identified through side-by-side comparison of labeled protein bands. In this 
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work, we detected proteins that were subject to translational up-regulation, 
down-regulation, or stabilization following treatment with HU.  
In order to visualize newly synthesized proteins, fluorescent dyes can be 
attached to Anl-tagged proteins in fixed cells. We examined global protein 
synthesis with temporal and spatial resolution and found that translation 
during S phase is primarily devoted to histone production. Histone synthesis 
and nuclear translocation were detected as increased fluorescence intensity 
within cell nuclei, and these intensities co-localized with nuclear staining, 
resembled the distribution of GFP-tagged histones, and were abolished by 
inhibition of histone translation. These observations were consistent with the 
amount of histones required for new chromatin assembly, as well as the cell-
cycle dependence of histone translation. In cells that were not in S phase, the 
distribution of newly synthesized proteins was broadly distributed with 
individual localized puncta that may represent proteins within the 
endoplasmic reticulum. 
N-terminal incorporation may be extended for interrogating protein 
synthesis in a cell-selective manner within cellular mixtures, heterogeneous 
tissue, or even multicellular organisms. This technique complements existing 
strategies for translational analysis of individual proteins,38 and combination 
of these methods may be especially powerful. Since non-canonical amino 
acids have many additional applications in protein engineering and 
molecular medicine,39,40 site-selective N-terminal incorporation may serve as a 
useful technology for producing modified protein therapeutics. N-terminal 
incorporation via selective intracellular aminoacylation of initiator tRNA is a 
novel strategy for expression of proteins containing non-canonical amino 
acids, and we anticipate future developments may extend this technology to 
introduce non-natural amino acids beyond Anl. 
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Figure 4.1 
 
 
NLL-MetRS permits incorporation of Anl into proteins synthesized in the 
mammalian cytoplasm. (A) Initiator tRNA (red cylinder) aminoacylated with 
Anl (green circle) is used to initiate protein synthesis from the start codon. 
Elongator-tRNAMet (blue cylinder) aminoacylated with Met (orange circle) is 
used for decoding internal AUG codons. N-terminally tagged proteins can be 
ligated to specific probes that permit their detection. (B) HEK293-8D3 and 
non-transfected cells were pulsed with Anl and incorporation of Anl is 
assessed by conjugation to AlexaFluor488-alkyne followed by fluorescence 
microscopy. HEK293-8D3 cells expressing the NLL-MetRS are able to 
incorporate Anl into proteins whereas non-transfected cells are not. (C) 
Proteins from pulsed HEK293-8D3 and control cells are examined for Anl 
incorporation by conjugation to DIBAC-TAMRA followed by in-gel 
fluorescence scanning. Numerous proteins from pulsed HEK293-8D3 cells 
are tagged with Anl. Proteins from non-transfected cells or cells not exposed 
to Anl did not exhibit TAMRA fluorescence. 
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Figure 4.2 
 
 
Enrichment and analysis of Anl-tagged proteins. Lysates were reacted with 
DIBAC-biotin (input, “I”), and biotinylated proteins were collected on 
immobilized streptavidin. The unbound fraction (flow-through, “FT”), and 
final wash “FW” were collected and compared to the elution “E.” The 
enrichment was followed by coomassie staining and by detection of 
biotinylated proteins using fluorescent streptavidin. (A) Proteins from non-
transfected cells pulsed with Anl were analyzed in a “mock enrichment” to 
assess the selectivity of the procedure. Untagged proteins were neither 
conjugation to DIBAC-biotin nor enriched. Consequently, no proteins were 
present in the elution except naturally biotinylated proteins and streptavidin. 
(B) Tagged proteins present in a lysate of HEK293-8D3 cells were conjugated 
to DIBAC-biotin and could be enriched. The red box indicates the band 
corresponding to PTBP. (C) Ion fragmentation spectrum of the N-terminal 
tryptic peptide of PTBP displaying mass shifts corresponding to Anl 
substitution and conjugation to DIBAC-biotin (+676), as well as Nα-
acetylation (+42). (D) The enrichment is followed by western detection of 
PTBP and β-actin. Both PTBP and β-actin are present in the enriched fraction. 
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Figure 4.3 
 
 
Histones synthesized by cells in S-phase are tagged with Anl. (A) HEK293-
8D3 cells were dye-labeled with AlexaFluor488-alkyne to reveal the 
distribution of tagged proteins synthesized during the pulse. Localized 
increased fluorescence intensity from AlexaFluor488 was observed in a 
subset of cells. These intensities co-localized with the emission of the nuclear 
stain Hoechst 33342, indicating that certain nuclei contained increased 
amounts of tagged protein. (B) Extracted histones were assessed for Anl-
incorporation by conjugation to DIBAC-TAMRA followed by detection by in-
gel fluorescence scanning. Lane 1 contains histones from HEK293-8D3 cells 
that were not treated with Anl. Lane 2 contains histones from Anl-treated 
HEK293-8D3 cells. Bands corresponding to the core histone proteins are 
labeled, indicating that histones synthesized by cells in S-phase are tagged 
during the pulse. 
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Figure 4.4 
 
 
Protein Synthesis in hydroxyurea-treated cells. Proteins from untreated and 
hydroxyurea (HU)-treated cells are assessed for Anl-tagging by conjugation 
to DIBAC-TAMRA followed by fluorescence scanning. HU is an inhibitor or 
DNA synthesis and histone translation. Total protein (A), and isolated 
histones (B) of HU-treated cells exhibit decreased fluorescence intensity at 
bands corresponding to core histone proteins. (C) Close inspection of 
TAMRA-labeled proteins reveals stabilization of p53, which is confirmed by 
western detection with anti-p53 antibody. (D) Cells in S-phase exhibit 
increased nuclear AlexaFluor488-alkyne fluorescence from tagged histones 
translated in synchrony with DNA replication.  When DNA synthesis is 
inhibited (+HU), histone translation is rapidly inhibited and nuclear 
intensities are not detected. 
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Supplementary Figure 4.1 
 
 
 
Amino acids and probes used in this study.  
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Supplementary Figure 4.2 
 
 
Selective aminoacylation of eukaryotic cytoplasmic initiator tRNA in vitro. 
Anticodon stem-loop structures of (A) E. coli initiator (“1”), and elongator-
tRNAMet (“2”), and (B) eukaryotic cytoplasmic initiator (“2”), and elongator-
tRNAMet (“4”). (C) Synthetically prepared tRNAs are aminoacylated using 
purified NLL-MetRS and Anl attachment is assessed by conjugation to a 
cyclooctyne-functionalized AlexaFluor488 and subsequently detected by in-
gel fluorescence scanning. The NLL-MetRS, like the wild-type E. coli MetRS, 
does not charge eukaryotic cytoplasmic elongator-tRNAMet. 
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Supplementary Figure 4.3 
 
Heterologous expression of the NLL-MetRS in mammalian cells. (A) 
Schematic of the gene construct encoding the His-tagged NLL-MetRS-
mCherry fusion as driven by the CMV promoter. (B) Color coded protein 
sequence of the encoded gene. (C) HEK293-8D3 cells exhibit mCherry 
fluorescence from expression of the synthetase-mCherry fusion and the 
protein is distributed throughout the cell. (D) Western analysis of non-
transfected (1) and HEK293-8D3 cells (2) with anti-mCherry revealed that the 
His-tagged NLL-MetRS-mCherry is translated to full length (91.4 kDa). (E) 
The NLL-MetRS-mCherry is fully intact and soluble, as this protein was 
affinity purified from the soluble cytoplasmic fraction of proteins via an N-
terminal His-tag.  
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Supplementary Figure 4.4 
 
 
Anl is incorporated into proteins synthesized in HEK293-8D3 cells. Cells 
were pulsed with Anl and assessed for Anl-incorporation in fixed cells by 
conjugation to AlexaFluor488-alkyne followed by detection by fluorescence 
microscopy. Non-transfected cells that do not express the NLL-MetRS do not 
incorporate Anl into proteins. HEK293-8D3 cells are able to introduce Anl 
into proteins as indicated by cellular fluorescence from attached 
AlexaFluor488-alkyne. To confirm that Anl was incorporated into proteins, 
HEK293-8D3 was co-incubated with Anl and the protein synthesis inhibitor 
anisomycin.  Protein synthesis inhibited-cells exhibited significantly 
diminished levels fluorescence from AlexaFluor488-alkyne. 
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Supplementary Figure 4.5  
 
The specificity of DIBAC-conjugation to Anl-tagged proteins is increased 
following cysteine alkylation with iodoacetamide. (A) Untagged histones 
exhibit background labeling with DIBAC-TAMRA at the band corresponding 
to Histone H3, the only cysteine-contain histone. This background labeling is 
diminished following alkylation cysteine with iodoacetamide. (B) 
Recombinant DHFR does not contain cysteine and untagged DHFR does no 
experience background labeling with DIBAC-TAMRA. A DHFR containing 7 
azidohomoalanine residues is conjugated to DIBAC-TAMRA. A complete 
band shift of the azide-containing DHFR indicates that the reaction is highly 
efficient. (C) Untagged proteins in lysates exhibit decreased background 
labeling at cysteine residues following alkylation with iodoacetamide. (D) 
DIBAC-TAMRA labeling is highly specific following alkylation of proteins.  
Fluorescence intensity of alkylated proteins following reaction with DIBAC-
TAMRA is compared to tagged proteins DIBAC-TAMRA, and proteins not 
exposed to DIBAC-TAMRA.   
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Supplementary Figure 4.6 
 
Anl-tagging under varying pulse concentrations and durations. Non-
transfected HEK293 and HEK293-8D3 cells were pulsed with the indicated 
concentrations of Anl for 4 h (A), or pulsed with 1 mM Anl for the indicated 
times (B). To assess Anl-tagging, lysates alkylated with iodoacetamide, 
reacted with DIBAC-TAMRA, and protein were examined by in-gel 
fluorescence scanning. Proteins gels were subsequently stained with 
coomassie to ensure even loading (10 µg of protein was loaded per lane). 
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Supplementary Figure 4.7 
 
 
Tagging and enrichment of constitutively expressed proteins. Proteins from 
pulsed (A) non-transfected cells (“mock enrichment”), and (B) pulsed 
HEK293-8D3 cells were processed in an enrichment protocol using DIBAC-
biotin and immobilized streptavidin. The enrichment was analyzed by 
western detection of the constitutively expressed “housekeeping” proteins 
GAPDH and β-actin. The lysate (input, “I”), flow-through (“FT”), final-wash 
(“FW”), and eluted (“E”) fractions were compared. As GAPDH and β-actin 
are continually synthesized, these proteins were tagged in pulsed HEK293-
8D3 cells and enriched from the corresponding lysate. The absence of 
GAPDH and β-actin from the eluted fraction of the “mock enrichment” 
demonstrates the selectivity of the method.   
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Supplementary Figure 4.8 
 
Estimation of the degree of enrichment. Purified GFPs (28.2 kDa) containing 
a single Anl or Met were mixed with untagged HEK293 lysate at a ratio of 
1:1,000 (w/w) and subjected to the enrichment procedure using DIBAC-
biotin or DIBAC-S-S-biotin. The extent of enrichment was examined by 
comparing the “spiked” lysate with the eluted fraction following enrichment. 
Proteins were stained with coomassie, or transferred to membranes analyzed 
by western detection with β-actin antibody, anti-PentaHis antibody (GFP), or 
streptavidin (biotin). (1) Unmodified GFP. (2) lysate spiked with Met-GFP 
reacted with DIBAC-biotin, and (3) the corresponding elution. (4) lysate 
spiked with Anl-GFP reacted with DIBAC-biotin, and (5) the corresponding 
elution. (6) lysate spiked with Met-GFP reacted with DIBAC-S-S-biotin, and 
(7) the corresponding elution. (8) lysate spiked with Anl-GFP reacted with 
DIBAC-S-S-biotin, and (9) the corresponding elution.  Anl-GFP was enriched 
from lysates with both DIBAC-probes, although less GFP was enriched with 
DIBAC-S-S-biotin. Using DIBAC-biotin, GFP was concentrated in the elution 
by over 3-fold. In all cases, untagged β-actin was not detected in the elution 
indicating that it was diluted by at least 120-fold.  
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Supplementary Figure 4.9 
 
 
Structures used to determine the mass modifications applied in the 
database search for Anl-containing peptides.  
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Supplementary Figure 4.10 
 
Sequence coverage of PTBP. Tryptic peptides are underlined in blue, and 
chymotryptic peptides are underlined in yellow. Met positions are 
highlighted in red. 
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Supplementary Figure 4.11 
Mass spectra of identified Anl-containing peptides. (A-G) (top) Anl-
containing peptides are highlighted yellow and the position of the Anl 
containing peptide is displayed in green. (middle) Spectrum corresponding 
to highlighted Anl-containing peptide. (bottom) Total sequence coverage of 
the associated protein is displayed with individual peptides highlighted in 
yellow. Modifications of any kind are shown in green (including Met-
oxidation, cysteine alkylation, Anl incorporation). Modifications 
corresponding to Anl-incorporation were detected only at N-terminal 
positions. 
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Supplementary Figure 4.11 cont. 
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Supplementary Figure 4.11 cont. 
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Supplementary Figure 4.11 cont. 
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Supplementary Figure 4.11 cont. 
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Supplementary Figure 4.12 
 
 
 
Subcellular fractionation of pulsed HEK293-8D3 cells. Anl-containing 
proteins were conjugated to DIBAC-TAMRA and total protein (whole cell) 
was compared to cytoplasmic and organellar proteins.  Cytoplasmic proteins 
are present in the whole cell and cytoplasmic fractions, as indicated by 
western detection of GAPDH. The whole cell and organellar fractions contain 
nuclear proteins, as indicated by western detection of Histone H4. The highly 
labeled bands in the 10-20 kDa range present in the whole cell and organellar 
fractions correspond to the core histones.  
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Supplementary Figure 4.13 
 
  
Differences in translational profiles can be accentuated. Unpulsed (Met) 
and pulsed (Anl) HEK293-8D3 cells were untreated or treated with HU 
(+HU). Tagged proteins enriched from Anl-treated HEK293-8D3 cells using 
DIBAC-biotin. (A) Enriched proteins were examined by coomassie staining 
(top, blue) and by streptavidin detection (bottom). (B) Proteins from 
untreated and HU-treated HEK293-8D3 cells were enriched and analyzed by 
streptavidin detection. Differences in band intensities are highlighted. Bands 
exhibiting decreased streptavidin intensity in the +HU lane are indicated 
with blue arrowheads. Bands exhibiting increased streptavidin intensity in 
the +HU lane are indicated with red arrowheads. 
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Supplementary Figure 4.14 
 
  
 
MetAP exhibits attenuated excision activity toward N-terminal Anl. (A) 
Structures of fluorogenic model substrates. (B) Saturation curves of Met-
AMC and Anl-AMC in reaction with recombinant human MetAP-2. (C) 
Kinetic constants determined by reaction of Met-AMC and Anl-AMC with 
MetAP-2. 
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Table 1. Detected peptides displaying evidence of Anl-incorporation  
  
  103 
Supplementary Table 1. MetAP processing of tagged proteins	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MATERIALS AND METHODS 
Tagging and Detection Reagents 
Azidonorluecine was synthesized as previously described but with Nα-Boc-
L-Lysine (Bachem) as the starting material in place of diaminobutyric acid 
(Link, A.J., et al, Nat. Protoc. 2, 1879—1883). TLC, 1H NMR, and mass 
spectrometry were used to confrim the structure and purity of the amino 
acid.  A stock solution of the amino acid was prepared at a concentration of 
100 mM in water and sterilized by passage through a 0.2 µm filter.  The 
solution were stored at 4 °C until use. Stocks of dibenzo-aza-cycloocytne-
carboxytetramethylrhodamine (DIBAC-TAMRA, Click Chemistry Tools), 
sulfo-dibenzo-aza-cycloocytne-biotin (DIBAC-biotin, Click Chemistry Tools), 
and dibenzo-aza-cycloocytne-S-S-PEG3-biotin (DIBAC-S-S-biotin, Click 
Chemistry Tools) were prepared at 10 mM in DMSO to 10 mM and stored in 
aliquots at -20 °C until use. All other materials from commercial suppliers 
were used without further purification as described in subsequent sections. 
The Click-iT Alexa Fluor 488 Protein Synthesis HCS Assay (product #C10289, 
Invitrogen) was used to prepare cells for fluorescence microscopy.  
Western Blotting and Antibodies 
Western blots were performed using standard procedures.  Briefly, following 
separation by SDS-PAGE, proteins were transferred to nitrocellulose and 
blocked in 5% (w/v) dry non-fat milk in TBST for at least 15 m.  Membranes 
were incubated with antibodies at the concentration described below using 
either blocking buffer or the manufacturer’s suggested buffer.  Membranes 
were washed three times with TBST for 5 m each before addition of 
secondary antibodies or detection on fluorescence scanner (Typhoon Trio+, 
GE Healthcare).  Mass approximations on blots (as well as for SDS-PAGE 
gels) were made using the pre-stained protein molecular weight marker 
SeeBlue Plus2 (Invitrogen). 
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Monoclonal Anti-GAPDH from mouse (Sigma) was used at 1:2,000. 
Monoclonal Anti-p53 from mouse (Sigma) was used at 1:1,000. Polyclonal 
Anti-DsRed from rabbit (Clontech) was used at 1:1,000. Monoclonal Anti-
Histone H4 (pan) from rabbit (Millipore) was used at 1:1,000. Monoclonal 
anti-β-actin from mouse (Sigma) was used at 1:2,000. Monoclonal Anti-
PentaHis-AlexaFlour647 primary conjugate (Qiagen) was used at 1:2,000. 
Secondary antibodies included Anti-Mouse-AlexaFlour647 conjugate from 
rabbit (Invitrogen) and Anti-rabbit-DyLight680 conjugate from goat (Cell 
Signalling). Streptavidin-AlexaFlour488 and Streptavidin-AlexaFlour647 
conjugates (Invitrogen) were used at 1:2,000. 
Cloning 
All primers were custom synthesized from Integrated DNA Technologies. 
Constructs were verified by DNA sequencing, which was performed by 
Laragen with the listed primers.  
The pmCherry-N1-NLL_MetRS encodes the N-terminally His-tagged NLL-
MetRS-mCherry under control of the CMV promoter and also contains a 
resistance marker for selection in bacterial and mammalian cells. In order to 
clone pmCherry-N1-NLL_MetRS, DNA encoding an N-terminally His-
tagged mutant E. coli methionyl-tRNA synthetase (Δ547, L13N, Y260L, 
H301L) was amplified by PCR from pQE80-NLL-MetRS with the primers 
XhoI_NLL_MetRS_F  and XhoI_NLL_MetRS_R. The resulting fragment was 
inserted into pmCherry-N1 (Clontech) between XhoI and XmaI sites using 
standard digestion and ligation procedures. The ligation mixture was 
transformed into competent DH10B E. coli (Invitrogen) and plasmid-carrying 
clones were selected on LB-agar plates containing 35 mg L-1 of kanamycin 
sulfate.  
pJS2-NLL is a bacterial expression plasmid that encodes an IPTG-inducible 
His-tagged mutant GFP containing a single Met site and also encodes the 
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NLL-MetRS under a constitutive promoter. In order to clone pJS2-NLL, DNA 
encoding a gene cassette for constitutive untagged NLL-MetRS was isolated 
from pJTN1 by digestion with NheI.  The isolated fragment was inserted at 
the NheI site of pJS2 using standard digestion and ligation procedures. The 
ligation mixture was transformed into competent DH10B E. coli and plasmid-
carrying clones were selected on LB-agar plates containing 200 mg L-1 of 
ampicillin. 
PCR Primer Sequences: 
XhoI_NLL_MetRS_F: 5’-AGATCTCGAGATGAGAGGATCGCATCACCA-3’ 
XmaI_NLL_MetRS_R: 5’-GGATCCCGGGTTTTAGAGGCTTCCACCAGTGC-3’ 
Sequencing Primers: 
pmCherryN1-NLL_seq_1F: 5’-GGTGGCGAAACAGGAAGG-3’ 
pmCherryN1-NLL_seq_2F: 5’-AAGACCATGGGCTGGGAG-3’ 
pmCherryN1-NLL_seq_1R: 5’-CATCAGCCTGGATGTGCTC-3’ 
pmCherryN1-NLL_seq_2R: 5’-GCAGTACCGGCTTCAGGTAA-3’ 
 
Transfection and Selection 
For transfection, pmCherry-N1-NLL_MetRS was isolated from DH10B E. coli 
using the EndoFree Plasmid Maxi Kit (Qiagen) according to the supplier’s 
protocol. A 30 mL suspension culture of the HEK293-F cell line (Invitrogen) 
was grown to a density of 1 x 106 cells/mL in 293FreeStyle media (Invitrogen) 
in a humidified incubator at 37 °C with 8% CO2 and 130 rpm shaking. Cell 
were transfected with 150 µg of pmCherry-N1-NLL_MetRS using 
polyethylenimine as the transfection reagent. Following transfection, the 
culture was allowed to grow for 48 h at which point an aliquot of cells were 
inspected by for mCherry fluorescence by microscopy. Roughly half of 
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surviving cells exhibited mCherry fluorescence. For selection of stable clones, 
a 10 mL aliquot of the cell suspension was transferred to a T-75 culture flask 
and cells were allowed to adhere to the flask surface for 24 hours. 
Subsequently, the media was exchanged for fresh 293FreeStyle medium 
containing 50 µg mL-1 of geneticin sulfate. Individual clones were isolated 
into 96-wel plates and maintained in pre-conditioned 293FreeStyle medium 
before exchange to increasing larger culture vessels. In total, ten lines were 
generated (including the characterized HEK293-8D3) with varying degrees of 
mCherry fluorescence. Cell stocks were prepared in 293FreeStyle media 
containing 5% dimethylsulfoxide and frozen overnight at -80 °C in a slow-
freezing container before submersion in liquid N2 for long-term storage. 
Cell Culture Maintenance 
Cell stocks of HEK293-8D3 and non-transfected HEK293-F were thawed 
plated in T-75 flasks containing 15 mL of DMEM +X with 10% FBS. After 48 
h, geneticin sulfate was added to the HEK293-8D3 culture to a final 
concentration of 50 µg mL-1. The culture was maintained over the course of 
experiments in cell-culture treated T-75 flasks (Corning) or on 100 mm cell-
culture treated culture dishes (BD Bioscience). The culture media was 
replenished every 1 – 3 days, depending on density. Cells passaged at ~80% 
confluence using trypsin-EDTA solution (0.05% Trypsin-EDTA, Invitrogen) 
and diluted into fresh media at between 1:10 and 1:20 dilution ratios. 
Cultures were discarded after ~20 passages and replaced with new cultures 
from frozen stocks. 
General Pulse Labeling Procedure 
Cells were prepared by exchanging the culture medium with fresh 
maintenance medium the day prior to pulse labeling. Cells at between 65 – 
85% confluence were pulsed by addition of Anl the culture medium at the 
indicated final concentration and incubated for the indicated time at 37 °C, 
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with 5% CO2. The pulse was stopped by aspiration of the culture medium at 
which point cells were rinsed once with room temperature PBS. Cells were 
collected by trypsinziation and centrifugation. Pelleted cells were rinsed once 
with PBS and the rinse solution was removed and the cell pellets were stored 
at -20 °C. 
Preparation of Cell Lysates 
Frozen cells were thawed on ice and suspended in 100 mM Tris HCl (pH 8.0) 
containing protease inhibitors (eComplete ETDA-free, Roche, 1 tablet/50 
mL), and 0.2% SDS (diluted from a 10% stock solution in water). Cells were 
lysed in this solution by pipetting and agitation. Chromosomal DNA was 
sheared by sonication on ice with 3 x 10 s bursts at 9 W with a 10 s pause 
between bursts. Protein concentrations were measured by BCA Protein Assay 
(Pierce) and normalized to 1 mg mL-1 with lysis buffer. Free thiols were 
blocked by iodoacetamide, which was added to a final concentration of 25 
mM (from a stock solution in water). The alkylation reaction was protected 
from light and placed on a rotator at room temperature for 1 h. The protein 
solution was then immediately frozen or further processed as described in 
subsequent sections.  
Protein Modification and Detection with DIBAC-functionalized Probes 
Alkylated lysates were reacted with DIBAC-probes by their addition to 
protein solutions from 100 mM stocks in DMSO. Reactions with DIBAC-
TAMRA were performed at a final concentration of 20 µM of the probe and 
incubated for 20 m protected from light and with rotation at room 
temperature. Reactions with DIBAC-biotin and DIBAC-S-S-biotin were 
performed at a final concentration of 20 µM for each probe and incubated for 
1 h with rotation at room temperature. Reactions were stopped by the 
addition of a five-fold excess of free Anl (relative to DIBAC-probe) followed 
by vortexing. 
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Sub-cellular Fractionation 
Cells were pulsed with Anl for 4 h and collected as described above before 
differential detergent fractionation using the Qproteome Cell Compartment 
Kit (Qiagen). Proteins were precipitated from the cytoplasmic and nuclear 
factions and resuspended in 100 mM Tris HCl pH 8.0 containing 0.2% (w/v) 
SDS and alkylated with iodoacetamide as described above. Fractions were 
compared with unfractionated total protein by reaction with DIBAC-TAMRA 
(as described above). 
Dye-Labeling of Fixed Cells with AlexaFluor488-alkyne 
HEK293-8D3 and non-transfected HEK293 cells were grown to ~80% 
confluence on 100 mm cell culture treated petri dishes, trypsinized and then 
seeded onto 8-well Lab-Tek II Chamber Slides (ThermoScientific) at a density 
of 2.5 x 104 cells per well. Cells were allowed to adhere by incubation in 
293FreeStyle or maintenance medium overnight at 37 °C, with 5% CO2. Cells 
in 293FreeStyle media did not adhere as well as those grown in the serum-
containing maintenance medium. The following day, the media was removed 
by gentle pipetting and replaced with pre-warmed 293FreeStyle or 
maintenance medium with or without 1 mM Anl. For protein synthesis 
inhibited controls, anisomycin was added to 40 µM by addition to the culture 
30 m prior to exposure to Anl and also after exchange with Anl-containing 
medium. Cells were incubated 4 h at 37 °C, with 5% CO2. Following the 
“pulse” the culture medium of each well was removed by gentle pipetting. 
Cells were gently rinsed once with room temperature PBS. Cells were labeled 
then fixed, permeablized, dye-labeled, and stained with Hoechst 33342 
according to the manufacturer’s instructions accompanying the Click-iT 
Alexa Fluor 488 Protein Synthesis HCS Assay.  
Fluorescence Microscopy
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All images were obtained with a Zeiss LSM510 confocal microscope using a 
20X or 40X lens, or a 63X oil immersion lens. 
For detection of mCherry, HEK293-8D3 and non-transfected HEK293 from 
liquid suspension culture in the 293FreeStyle medium were plated onto 
black-well clear-bottom 96-well poly-D-Lysine plates (Fisher) at ~5 x 103 wells 
per well. Cells were allowed to adhere overnight before imaging the next 
day. 
Histone Extractions 
Frozen cell pellets were resuspended in 3 mL of cold PBS with 0.5% (v/v) 
Triton X-100 containing eComplete EDTA-free protease inhibitor cocktail at 1 
pellet per 50 mL.  Cells were lysed gentle pipetting followed by a 10 m 
incubation on ice. Nuclei were sedimented by centrifugation at 2,000 x g for 
10 m at 4° C.  The supernatant was collected pelleted nuclei were 
resuspended in an additional 1.5 mL of cold PBS with 0.5% Triton X-100 to 
ensure efficient lysis. Nuclei were sedimented again. Histone extraction was 
performed by resuspension of the nuclear pellet in 0.5 mL 0.2 N HCl and 
incubated overnight with rotation at 4 °C. The following day, samples were 
centrifuged at 2,000 x g for 10 m at 4 °C to sediment nuclear debris.  The 
supernatant containing acid-soluble nuclear proteins (including histones) 
was collected. Prior to protein modification, the solution pH was raised by 
the addition of an equal volume of 1 M Tris pH 8.0 containing 1% (w/v) SDS. 
Model Protein Expression in E. coli and Purification 
DH10B E. coli transformed with pJS2-NLL and pREP4 and maintained using 
100 mg L-1 ampicillin and 35 mg L -1 kanamycin. Cells grown overnight in LB 
were diluted 1:50 in M9 minimal medium containing supplemented with 40 
mg L-1 of each of the 20 amino acids 1 mM MgSO4, 0.1 mM CaCl2, 30 mg L-1 
thiamine hydrochloride, and 0.4% (w/v) glucose.  When cells reached an 
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OD600 of 1.0, the culture was sedimented by centrifugation at 8,000 x g for 5 m 
at 4° C and washed with 0.9% NaCl (w/v) solution in water.  The was 
repeated once before cells were resuspended in the same medium with 
without Met and instead containing 1 mM Anl and 1 mM IPTG. After a 4 h 
expression, cells were collected. Affinity purification of the His-tagged GFP 
containing 1 Anl was performed on Ni-NTA resin (Qiagen) according to the 
manufacturer’s protocol for purification under native conditions. The 
purified protein was buffer exchanged into PBS using PD-10 columns (GE 
Healthcare) and quantified by BCA protein assay. 
Enrichment of Anl-labeled Proteins 
T-75 flasks of cells were pulsed for 6 h as described above using 2 mM Anl. 
Lysates were prepared as described above such that the final volume of the 
solution was ~2 mL following alkylation. Proteins were biotinylated as 
described above. Excess biotin reagent was removed from the quenched 
reaction by two successive gel filtration steps using PD-10 Desalting Columns 
(GE Healthcare). New columns were equilibrated with 100 mM Tris pH 8.0 
with 0.2% (w/v) SDS prior to sample loading. In the first step, proteins were 
desalted according to the “spin protocol” described by the supplier. In the 
second step, proteins were desalted again on new and equilibrated columns 
according to the “gravity flow” protocol provided by the manufacturer. A 50 
µL aliquot of eComplete protease inhibitor cocktail was added to the elution 
from a concentrated stock of 1 tablet/mL. Biotinylated proteins were 
collected on Streptavidin Plus UltraLink Resin (Pierce) by adding 250 uL of a 
50 % slurry each solution as and incubating the suspension overnight at room 
temperature with rotation. The following day, the suspension was loaded 
onto a disposable chromatography column (1 mL capacity) and the flow-
through was collected by drip-flow. The resin was washed once with 100 mM 
Tris pH 8.0 containing 0.2% (w/v) SDS, once with 100 mM Tris pH 8.0 
containing 1.0% (w/v) SDS, once with a 6 M urea solution in 100 mM Tris pH 
8.0, once with a 1 M NaCl soluition in 100 mM Tris pH 8.0, and finally once 
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again with 100 mM Tris pH 8.0 containing 0.2% (w/v) SDS. Each wash was 
performed using 20-fold of the resin bed volume (2.5 mL). The entire wash 
procedure was repeated once before proteins were eluted from the resin by 
boiling in reducing SDS-PAGE loading buffer. 
Model Protein Enrichment 
The GFP containing 1 Anl (expressed and purified as described above) was 
added to HEK293 lysates at a ratio of 1:1,000 (3 µg of GFP added to 3 mg of 
lysate).  Proteins were enriched using DIBAC-biotin or DIBAC-S-S-biotin as 
described.  The enrichment was analyzed by coomassie staining of protein 
gels, and by western detection of beta-actin, His-tagged GFP, and 
streptavidin.  Coomassie stained gels were analyzed by densitometric 
analysis using ImageQuant (GE Healthcare). 
Analysis by Mass Spectrometry 
Proteomic analysis was performed at the Protein Exploration Laboratory 
(California Institute of Technology, Pasadena, CA). Proteins separated by 
SDS-PAGE and peptides were generated by in-gel digest according to a 
previously described detailed procedure (Shevchenko, A., et al. Nature 
Protocols 1, 2856 – 286).  Proteins were digested in separate reactions with 
either sequencing grade trypsin or chymotrypsin. Extracted peptides were 
dried by rotary vacuum and resuspended in 0.1% formic acid in water (v/v) 
before were analysis on a Thermo Scientific LTQFT mass spectrometer. 
Database Searching 
All MS/MS samples were analyzed using Mascot (Matrix Science, London, 
UK; version Mascot). Mascot was set up to search the 
IPI_human_wDEC.v3.54j database (unknown version, 151385 entries) 
assuming the digestion enzyme trypsin. Mascot was searched with a 
fragment ion mass tolerance of 0.50 Da and a parent ion tolerance of 10.0 
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PPM. Iodoacetamide derivative of cysteine was specified in Mascot as a fixed 
modification. Oxidation of methionine, met->ANL of methionine, acetylation 
of the n-terminus, DSSB cleaved of methionine and DSSBc+Acetyl of 
methionine were specified in Mascot as variable modifications.  
Criteria for Modification: Scaffold (version Scaffold_3_00_07, Proteome 
Software Inc., Portland, OR) was used to validate MS/MS based peptide and 
protein identifications. Peptide identifications were accepted if they could be 
established at greater than 90.0% probability as specified by the Peptide 
Prophet algorithm (Keller, A et al Anal. Chem. 2002;74(20):5383-92).  Protein 
identifications were accepted if they could be established at greater than 
90.0% probability and contained at least 2 identified peptides.  Protein 
probabilities were assigned by the Protein Prophet algorithm (Nesvizhskii, 
AI Anal Chem. 2003 Sep 1;75(17):4646-58). Proteins that contained similar 
peptides and could not be differentiated based on MS/MS analysis alone 
were grouped to satisfy the principles of parsimony. 
Hydroxyurea Treatment 
Hydroxyurea (Sigma) was added to cultures of HEK293-8D3 to a final 
concentration of 2.5 mM from a 1.25 M stock in water and pulsed with Anl 
five minutes later.  Cells were pulsed for 4 hours before proteins were 
collected and analyzed as described in preceding sections. 
Aminoacylation of synthetically prepared tRNA 
NLL-MetRS was expressed an purified as previously described.13 Synthetic 
tRNAs were prepared by the run-off transcript method and aminoacylated 
with Met or Anl as previously described.18 We use the cytoplasmic initiator 
and elongator-tRNAMet sequences from C. elegans (which was similar to the 
mammalian sequences), and initiator and elongator-tRNAMet sequences E. 
coli. Aminoacylated tRNAs were stabilized by acetic anyhydride as 
previously described (Walker, S.E., Fredrick, K., Methods. 44, 81—86). Nα-
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acyl-aminoacyl-tRNAs were precipitated with ice-cold 70% ethanol in water 
by standard mehods. Precipitated tRNAs were normalized and resuspended 
in 100 mM TRIS pH 7.0 with RNase inhibitor and labeled with DIFO-
AlexaFluor488 (a gift from Carolyn Bertozzi, UC Berkeley).  Excess dye was 
removed using BioSpin gel filtration columns (BioRad). tRNAs were 
separated on 2% aragose and imaged on a Typhoon Trio+ (GE Healthcare). 
MetAP Enzymatic Assay 
The fluorogenic substrates methionine-7-amino-4-methylcoumarin (Met-
AMC, Enzo Life Sciences) and azidonorleucine-7-amino-4-methylcoumarin 
(Anl-AMC, custom synthesis from Anaspec) were used in kinetic assays of 
purified recombinant human methionine aminopeptidase 2 (MetAP2, Enzo 
Life Sciences). Reactions were performed in 30 mM HEPES buffer (pH 7.4), 
150 mM NaCl, 100 µM CoCl2, and carried out in black 96-well plates. 
Substrate was added to each reaction well at concentrations ranging from 0 - 
1000 µM and with a final concentration of 4% DMSO to ensure substrate 
solubility. Reactions were initiated by addition of 1 µL of MetAP2 from a 0.5 
mg/mL stock, giving a final enzyme concentration of 7.14 nM. The change in 
fluorescence of each reaction was measured in a plate reader with excitation 
380 nm and emission detection at 460 nm. Triplicate measurements were 
averaged and fit to the Michaelis-Menten equation using Origin. 
Purification of the MetRS from HEK 293F-8D3 
To collect soluble cytoplasmic proteins, HEK293-8D3 cells were lysed in 1% 
(v/v) Triton-X100 solution in PBS with protease inhibitors. The N-terminally 
His-tagged NLL-MetRS-mCherry was purified from the lysate of HEK293-
8D3 cells using magnetic Ni-NTA agarose beads (Qiagen) according to the 
manufacturer’s protocol.  As a control, the purification was also performed 
using a lysate of non-transfected HEK293 cells. Proteins were analyzed by 
separation on 9% polyacrylamide SDS-PAGE gels and stained with 
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coomassie.  We confirmed that the protein purified from HEK293-8D3 cells 
was indeed the NLL-MetRS-mCherry by in-gel tryptic digestion of the gel 
fragment containing the band and LC/MS/MS analysis of extracted peptides 
as described above. 
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CHAPTER V 
Toward Cell-Specific Labeling of Proteins in  
Multicellular Organisms  
 
INTRODUCTION 
Cell type-specific expression of genes is fundamental to multicellular life.  
Expression of specific sets of proteins plays an essential role in defining both 
the identity and the functional state of the cell (Tomancak, 2007).  The human 
body contains more than 200 individual cell types, all sharing a single 
genome; each cell type is distinguished by the set of genes it expresses.  The 
genes expressed define the cellular proteome, which in turn dictates cellular 
behavior and gives each cell type its characteristic features (localization, 
morphology, metabolic state, etc).  Because of the heterogeneity of cell types 
in whole organisms, proteomic analysis on the level of a single cell type is 
challenging.  Data from in vivo proteomics (or protein expression data 
derived from complex cellular mixtures) can be difficult to interpret; small 
changes in a subset of the cells can be hard to detect and the cellular origins 
of detected proteins can be difficult to assign.  We propose here an approach 
that we believe will provide a powerful and general solution to the challenge 
of acquiring time-resolved, cell type-specific proteomic data from living 
animals. 
In 2006, we introduced the BONCAT (bio-orthogonal non-canonical amino 
acid tagging) method, a strategy for selective enrichment and identification of 
newly synthesized proteins in cells (Dieterich, et al, 2006).  The BONCAT 
method involves pulse-labeling of cells with the non-canonical amino acid 
azidohomoalanine (Aha) a surrogate for methionine.  Proteins made during 
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the pulse are labeled with Aha and are therefore subject to selective 
conjugation to alkyne-functionalized affinity probes via the Cu (I) catalyzed 
azide-alkyne cycloaddition reaction. Newly synthesized, affinity-tagged 
proteins can be enriched from the preexisting, unlabeled protein pool and 
identified by mass spectrometry.  For visualization of newly synthesized 
proteins, proteins pulse-labeled in the same fashion can be conjugated to 
dyes for tracking by fluorescence microscopy (Beatty, et al, 2005; Beatty, et al, 
2006). 
Recent work from our laboratory has built on the BONCAT approach to 
achieve cell-selective labeling of proteins in mixtures of cultured cells (Ngo, 
et al, 2009). Escherichia coli cells expressing the L13N/Y260L/H301L mutant 
form of the methionyl-tRNA synthetase (NLL-MetRS) can use the non-
canonical amino acid azidonorleucine in translation (Tanrikulu, et al, 2009). 
Cells that do not express the mutant enzyme are inert to Anl; in a cellular 
mixture, only proteins from mutant cells are labeled. Through this approach, 
proteins synthesized in targeted cells can be selectively isolated from 
complex mixtures for identification by mass spectrometry or conjugated to 
fluorescent dyes for in situ visualization.  
Cell-selective protein labeling in living animals is perhaps the ultimate test of 
a selective labeling.  We envision that cell-selectivity in vivo can be achieved 
in much the same fashion as in cell culture: confining expression of the NLL-
MetRS to selected cells should restrict labeling to these cells even in living 
animals.  The nematode C. elegans serves as an ideal model system for the 
development of cell-selective protein labeling methods, for a variety of 
reasons.  C. elegans is a multicellular organism for which full genome 
sequence data is available, making it suitable for proteomic interrogation.  
Reliable methods have been developed for rapid generation of transgenic 
animals, allowing for fast screening of a variety of platforms for NLL-MetRS 
expression (Mello et al, 1991).  The small size and transparency of the worm 
allow for observation of cellular phenomena in the intact organism with light 
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microscopy with single cell resolution.  Furthermore, C. elegans has a defined 
cell number with a completely characterized cell lineage (Sulston, 1977; 
Sulston, 1983), and a catalog of cell-specific promoters that drive gene 
expression in nearly every cell type can be compiled from the literature 
(Hunt-Newbury et al, 2007).  We proposed the use of cell-type specific 
transcriptional enhancers to regulate expression of NLL-MetRS in C. elegans, 
such that protein labeling with Anl is restricted to selected cell types in Anl-
fed worms. 
PRELIMINARY WORK 
In a preliminary analysis, we asked whether or not a non-canonical amino 
acid fed to C. elegans could be uptaken and incorporated into proteins. To 
examine this, we provided worms with Aha and interrogated C. elegans 
proteins for evidence of the azide-containing amino acid. Our intention was 
to employ Aha as a proxy for Anl in order to develop a feeding strategy that 
would eventually be used to deliver Anl to worms. Since Aha is a substrate 
for wild-type MetRS and can be incorporated into to proteins using 
endogenous machinery, standard laboratory strains of C. elegans could be 
tested without needing to create a transgenic organism.  
The most common food source for laboratory C. elegans is Escherichia coli. 
Thus, we employed E. coli as a vehicle for delivery of Aha to worms. In order 
to maximize the amount of Aha provided to worms, we prepared heavily 
labeled E. coli. Briefly, a culture of methionine auxotrophic E. coli at an OD600 
of 1.0 was pelleted and cells were resuspended in synthetic medium that did 
not contain Met. Aha was added to the culture and expression of a mutant 
GFP using IPTG. We induced GFP to ensure that bacterial cells contained an 
abundant level of Aha-containing protein. Following a 6 h labeling, bacterial 
cells were collected. Amino acid analysis of total protein extracted from the 
Aha-labeled E. coli revealed that Met and Aha were in equal abundance, and 
that Aha accounted for 0.8% of total amino acid content.  
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Aha-labeled E. coli were fed to a suspension culture of worm in liquid 
medium (S basal). As a control, a separate culture was fed unlabeled (or Met-
labeled) E. coli. After an overnight feeding, we noticed much of the bacteria 
added each culture had been consumed. To assess Aha incorporation in 
worms, total protein was extracted and conjugated to an alkyne-
functionalized fluorescent dye (alkyne-TAMRA) via Cu (I) catalyzed azide-
alkyne ligation.  Subsequently, proteins were separated by SDS-PAGE and 
labeled proteins were detected by fluorescence scanning.  Proteins from C. 
elegans fed Aha-labeled E. coli exhibited incorporation of Aha into numerous 
proteins as indicated by strong fluorescence intensity from alkyne-TAMRA 
(Fig. 1A). Proteins from C. elegans fed unlabeled E. coli did not exhibit 
TAMRA fluorescence. 
In order to be certain that the detected proteins were C. elegans proteins, and 
not proteins from the Aha-labeled E. coli, we performed western analysis of 
protein extracts with streptavidin (Fig. 1B). In lanes containing C. elegans 
proteins, we did not detect the naturally biotinylated biotin-carboxyl carrier 
protein (17 kDa) characteristic to E. coli lysates.  This result suggested that the 
C. elegans lysate was predominantly composed of C. elegans proteins, and that 
TAMRA intensity was from dye-conjugation to C. elegans proteins. 
To confirm that C. elegans proteins were indeed labeled, we conjugated 
alkyne-coumarin to proteins in fixed and permeablized worms. Detection of 
coumarin by fluorescence microscopy revealed labeling throughout worms 
fed Aha-labeled E. coli (Fig. 2). Control worms fed unlabeled E. coli exhibited 
only background levels of fluorescence. 
FUTURE WORK 
Extension of cell-selective labeling to multicellular organisms would 
constitute an important step forward for proteomic analysis. The preliminary 
work described here provides a strategy for delivery of non-canonical amino 
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acids to C. elegans, as well as validation that non-canonical amino acids can be 
incorporated into proteins within C. elegans. Cell-selective labeling will 
require generation of transgenic worms expressing NLL-MetRS (or another 
mutant synthetase) under control by cell-specific drivers. Validation of the 
proposed model system will establish a powerful platform for cell-selective 
protein labeling and identification not only in C. elegans, but in any number of 
cell types in various organisms. This approach will allow simplification of 
proteomic data derived from live animals and permit single-cell dissection of 
proteome dynamics.   
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Figure 5.1 
 
Detection of Aha-tagged C. elegans proteins. (A) Proteins C. elegans fed Aha-
labeled or Met-labeled E. coli cells were extracted and assessed for Aha-
incorporation by reaction with alkyne-TAMRA.  In-gel fluorescence scanning 
was used to detect labeled proteins. Numerous proteins from C. elegans fed 
Aha-labeled E. coli exhibited TAMRA fluoresence (B) The characteristic 17 
kDa biotinyateld E. coli protein (biotincarboxyl-carrier protein) was not 
detected the lanes containing to proteins extracted from C. elegans fed Aha-
labeled or unlabeled E. coli. 
 
  
  126 
Figure 5.2 
 
Visualization of Aha-tagged proteins in C. elegans. C. elegans fed Aha-
labeled or unlabeled E. coli were fixed, permeablized, and conjugated to 
alkyne-coumarin.  Detection of coumarin by fluorescence microscopy 
revealed the presence of Aha-containing proteins through worms fed Aha-
labeled E. coli. 
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CONCLUDING REMARKS 
The methods described in this thesis were designed with the objective of 
providing powerful and adaptable methods for the study of protein synthesis 
in complex multicellular systems. These strategies combine the exquisite 
selectivity of bio-orthogonal chemistry with the versatility of genetic control 
to permit a level of temporal and spatial resolution that is not achieved using 
traditional techniques. The cell-selective and promoter-driven strategies are 
currently in use by multiple laboratories for dissection of host-pathogen 
interactions, bacterial biofilm communities, as well as multicellular 
organisms. The method for selective N-terminal incorporation is a novel 
strategy for incorporation of non-canonical amino acids and we anticipate 
that it will be a valuable tool for both proteomics and protein engineering. A 
future challenge may include adaptation of these techniques to examine 
spatial differences in protein translation within individual cells (such as 
localized protein synthesis within neurons).  
  
 
